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  ABSTRACT 
In mammals, formation of the primordial follicle is a complex process involving the breakdown 
of germ cell cysts, where oocytes must separate from each other and subsequently become 
surrounded by somatic cells. As cysts separate, a large number of germ cells are lost by 
apoptosis, however the mechanisms by which cyst breakdown and germ cell death occur are not 
well understood. We first hypothesized that two anti-apoptotic regulators from the BCL2 family 
of proteins, BCL2 and MCL1, may be responsible for regulating neonatal oocyte survival. To 
elucidate the effects of BCL2 in the neonatal ovary, we examined ovaries of both Bcl2 
overexpressing and knockout transgenic mice. When compared to wild-type mice, neither Bcl2 
overexpression nor abrogation significantly altered ovarian histology. Another BCL2 family 
protein, MCL1, is expressed in human oocytes during ovarian development, suggesting a role for 
MCL1 in oocyte survival. We found that MCL1 was localized to both oocytes and somatic cells 
during cyst breakdown. Subsequently, we used an in vitro organ culture system to identify a role 
for MCL1 in oocyte survival. We found that inhibition of MCL1 with an antibody to MCL1 in 
culture resulted altered germ cell numbers and oocyte cyst breakdown. Our data demonstrate that 
while BCL2 is not likely involved in perinatal oocyte survival, MCL1 may be an important 
regulator of the ovarian primordial follicle reserve.  Next, we hypothesized that the KIT 
signaling pathway may be important for oocyte survival and cyst breakdown in the neonatal 
ovary. The tyrosine kinase receptor, KIT, and its ligand, KITL, have been implicated in oocyte 
survival and follicle development in both fetal and adult ovaries but have not been well studied at 
the perinatal time point. To elucidate the functional role of KIT signaling in the neonatal ovary, 
we began by using immunohistochemistry to test the expression of KIT and KITL. We found 
both proteins to be expressed in the developing ovary from 17.5 dpc to PND 3, suggesting an 
  
important role for this protein in cyst breakdown or oocyte survival. To test this hypothesis, 
ovaries from 17.5 dpc fetal mice were cultured for 5 days in control media, or in media with the 
KIT blocking antibody, ACK2, or recombinant KITL. Our data demonstrated a role for KIT 
signaling in cyst breakdown, as inhibition and activation of the pathway altered ovarian 
histology.  Using cell proliferation and TUNEL assays at the conclusion of culture, we identified 
a reduction in somatic cell proliferation when KIT signaling was inhibited and likewise, a 
decrease in cell death. Finally, we investigated which pathway downstream of KIT affects cyst 
breakdown and the effect of KIT signaling on MCL1 protein expression.  After 3 days in culture 
with KITL supplemented media, Western blotting was used to analyze the total and 
phosphorylated forms of proteins from the PI3K, MAPK and JAK-STAT pathways as well as the 
BCL2 family protein, MCL1.  We found that there was an increase in the phosphorylated forms 
of p44/p42 in the MAPK pathway and a downregulation of MCL1 on KIT activation.  Overall 
our data have shown that while BCL2 may not contribute to oocyte survival during cyst 
breakdown, both MCL1 and KIT play important roles in formation of the primordial follicle 
pool. 
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CHAPTER 1: 
INTRODUCTION 
Significance 
 The number of germ cells available to a female mammal at birth is a finite number that 
decreases as the female matures and eventually reaches the period of reproductive senescence 
(Kim & Tilly 2004).  Not only is she initially limited in the number of oocytes allotted to her at 
birth, but any abnormalities in the development of these cells can further reduce numbers, 
leading to infertility.  Infertility has been associated with various reproductive disorders, 
including premature ovarian failure, polycystic ovary syndrome, and primary amennorhea; 
nevertheless the etiology of many infertility issues remains unknown. In addition to disorders of 
conception, ovarian cancers are common in the human population.  One specific type of cancer, 
ovarian dysgerminoma, involves germ cell tumors.  The exact pathophysiology of how these 
tumors arise remains a mystery. Procuring a basic understanding of early follicle development, 
regulation of follicle numbers and oocyte differentiation may aid in the pursuit of treatments for 
infertility and germ cell tumors of both known and unknown etiologies. 
 
Fetal germ cell development 
 In mouse, between 6.5 and 7 days post-coitum (dpc), a small subset of cells in the 
developing embryo become committed to a germ cell fate, and are first identifiable at 7 dpc by 
alkaline phophatase positivity in the posterior primitive streak (Saffman & Lasko 1999).  These 
primordial germ cells migrate to the genital ridge at about 10.5 dpc and begin dividing by mitosis 
to dramatically increase the number of germ cells (Fig. 1.1; Peters 1970).  The now large number 
of oogonia are found at the prospective ovary in clusters of synchronously dividing cells known 
2 
 
as germline cysts (Pepling & Spradling 1998). Cysts are groups of germ cells that remain 
connected due to incomplete cytokinesis, and intercellular bridges are found between 
neighboring cells within a cyst (Pepling & Spradling 1998). At 13.5 dpc, the oogonia cease 
mitosis and begin to enter meiosis progressing through the stages of prophase I from 13.5 dpc 
until their arrest in the diplotene stage, beginning at 17.5 dpc.  Meiosis appears to occur in 
waves, initiated in oocytes populating the anterior ovary at 13.5 dpc and arresting in the 
diplotene stage of meiosis at 17.5 dpc, while oocytes in the posterior of the ovary may not arrest 
until five days after birth (Borum 1961, Menke et al. 2003).   
 Around the time of diplotene arrest, germ cell cysts begin to break down.  This begins in 
the medulla, or innermost portion of the ovary, at 17.5 dpc and occurs in the cortical, or outer 
region of the ovary between 19.5 dpc and PND 4 in the mouse (Pepling et al. 2010). 
Coincidentally, as the cysts break down, two-thirds of oocytes are lost by apoptosis (Pepling & 
Spradling 2001). 
 
Cyst formation, cyst breakdown and primordial follicle formation 
 Germline cyst formation is highly conserved. Many species, including rat, mouse, 
hamster, rabbit, human, frog, fruit fly, sheep, cattle and pig display the characteristics of 
germline cysts, such as synchronous division or intercellular bridge connections (Russe. 1983, 
Smith et al. 1993, Pepling et al. 1999, Bielanska-Osuchowska  2006).  As oocyte cysts form, 
they become arranged into structures called 
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ovigerous cords which consist of layers of somatic cells, called pregranulosa cells, surrounding 
oocyte cysts (Mazaud et al. 2005). These structures are evident by 13.5 dpc (Pepling & Spradling  
2001).  In order for primordial follicle formation to occur, these ovigerous cords must break 
apart in the process of cyst breakdown. Cyst breakdown results in the formation of primordial 
follicles, which consist of an oocyte surrounded by a single layer of somatic granulosa cells. As 
part of the cyst breakdown process, surrounding granulosa cells begin to intrude between 
oocytes, and it is thought that this contributes the formation of primordial follicles (Pepling & 
Spradling  2001). In some instances, the adult ovary will contain follicles with more than one 
oocyte enclosed within the granulosa cells, and these structures are known as multiple oocyte 
follicles (MOFs; Fig. 1.2).   MOFs are thought to be oocyte cysts that did not properly break 
down (Jefferson et al. 2006). 
 Although not much is known about oocyte cyst breakdown and the formation of 
primordial follicles, research is beginning to uncover various molecules that play a role in these 
processes. The Notch family of proteins have increasingly been implicated in controlling cyst 
breakdown and primordial follicle formation. Johnson et al. (2001) first examined the expression 
of components of this pathway in the 6 week old mouse ovary and found the Notch receptors 
NOTCH 2 and NOTCH 3 to be expressed in granulosa cells along with the ligand JAGGED1.  
The Notch ligand, JAGGED 2, was localized to oocytes, suggesting a possible role for these 
proteins in communication between germ cells and granulosa cells in folliculogenesis.  Lunatic 
fringe, a protein involved in regulation of Notch signaling, is expressed in the granulosa cells of 
mouse ovaries (Hahn et al. 2005).  Knockout of this protein results in MOFs  
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so these mice may have defects in cyst breakdown, although this has not been specifically 
examined.  Another study examining the effects of Notch signaling on ovarian development 
identified the importance of this signaling pathway specifically in cyst breakdown and primordial 
follicle formation.  Trombly and colleagues (2009), found the ligand JAGGED 1 expressed in the 
oocytes of newborn mouse ovaries and the NOTCH 2 receptor expressed in granulosa cells.  In 
the same study, when Notch signaling was blocked in an ovary organ culture, cyst breakdown 
and primordial follicle formation were inhibited. 
 Experiments have also demonstrated a role for Neurotrophin signaling in primordial 
follicle formation.  In the ovary, Neurotrophin signaling either occurs through the binding of the 
ligand, Nerve Growth Factor (NGF) with its cognate receptor, Tropomyosin-Related Kinase A 
(TRKA) or through the binding of either Brain Derived Neurotrophic Factor (BDNF) or 
Neurotrophic Factor 4 (NT4) with their cognate receptor, TRKB (Dissen et al. 2002).  Spears et 
al. (2003), found that blocking PND 1 ovaries in culture with both BDNF and NT4 antibodies 
resulted in a marked reduction in the number of germ cells and an increase in the percent of 
dying cells in treated ovaries.  In the same study, TRKB knockout ovaries contained fewer 
oocytes than wild type controls at PND 4.  More recently, it was shown that both TRKA and 
TRKB knockout mice contained ovaries with fewer primordial follicles and more oocytes in 
cysts at PND 2. Using a Terminal Deoxynucleotidyl Nick End Labeling (TUNEL) analysis the 
authors also examined cell death in these ovaries and found no differences in the number of 
dying cells between control and TRKA or TRKB ovaries, demonstrating a role for both receptors 
in cyst breakdown and primordial follicle formation (Kerr et al. 2009).  Likewise, NGF mutants 
show a defect in primordial follicle assembly at PND 2.  NGF knockout ovaries have a decrease 
in the number of primordial and primary follicles, but an increase in oocytes found in cysts.  In 
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addition, there was a decrease in somatic cell proliferation, indicating a need for NGF in 
granulosa cell mitosis that may lead to primordial follicle formation (Dissen et al. 2001) . 
 There is evidence that several of the Transforming Growth Factor Beta (TGFB) family of 
proteins may be involved in cyst breakdown and follicle formation.  Activin, expressed in the 
germ cells of newborn mice, increased primordial follicle formation and the number of 
primordial follicles in mice treated with recombinant Activin (Bristol-Gould et al. 2006).  The 
effect appeared to be through an increase in granulosa cell proliferation, indicating an importance 
for Activin signaling in somatic cell mitosis during follicle formation.  Further evidence that 
Activin regulates follicle formation comes from mice mutant for the protein Follistatin, a 
negative regulator of Activin. These mice also have increased numbers of primordial follicles, 
however cyst breakdown occurs over a longer period of time (Kimura et al. 2011).  Mice mutant 
for two other TGFB family members, Growth and Differentiation Factor 9 (GDF9) and Bone 
Morphogenetic Protein 15 (BMP15), have ovaries that contain MOFs when both proteins are 
concurrently deleted (Yan et al. 2001).  Further, hamster ovaries exposed to GDF9 siRNA in 
culture show a reduction in primordial follicle formation, suggesting that the MOFs seen in 
double knockout mice may be due to aberrant cyst breakdown (Wang & Roy 2006).  Another 
TGFB protein, TGFB2, also affects formation of primordial follicles.  Knockout of this protein 
resulted in accelerated formation of the primordial follicle pool at PND 1, implying that TGFB2 
is a negative regulator of cyst breakdown (Memon et al. 2008). Finally, experimental data on the 
Bone Morphogenetic Protein (BMP) antagonist, Gremlin (GREM1), may indirectly shed light on 
the role of BMPs in ovarian development.  Upon observing the ovaries of Grem1 knockout mice, 
Myers and colleagues (2011) discovered that lack of this protein led to a reduction in the number 
of oocytes but an increase in the number found in germ cell cysts. This indicates a role for one or 
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more BMPs in regulating both germ cell numbers and primordial follicle formation, however the 
direct role of BMPs in these processes remains to be examined. 
 
Folliculogenesis 
 At the conclusion of cyst breakdown, the ovary is populated with a pool of primordial 
follicles arrested in the diplotene stage of prophase I.  This is considered the resting pool of 
follicles from which a few be selected to grow and ovulate, however many will die before 
activation (Faddy et al. 1976). Once primordial follicles are formed, some are activated, or 
selected to develop further (Fig. 1.3). Activated primordial follicles will first transition into 
primary follicles as the flattened granulosa cells surrounding the oocyte divide and become 
cuboidal (Zamboni 1974). Next, oocytes will grow and continue to accumulate more layers of 
somatic cells around them. Primary follicles that have increased in size and have gained multiple 
layers of granulosa cells are called secondary, or preantral follicles (Hirshfield 1991). In the 
secondary follicle phase, oocytes undergo significant growth, gain more granulosa cells and a 
new layer of theca cells that are derived from the stromal cells. These follicles will eventually 
gain a fluid filled space, or antrum, and become antral follicles (Hirshfield 1991).  Antral follicle 
survival is Follicle Stimulating Hormone (FSH) dependent, and those that are selected for 
ovulation will resume meiosis upon a surge of Luteinizing Hormone (LH) 
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and subsequently arrest in metaphase II until fertilization, a process called oocyte maturation.  
Just prior to ovulation, the oocyte nucleus, termed the germinal vesicle, will break down and 
meiosis will proceed from the diplotene stage of prophase I to metaphase of meiosis II (Wiersma 
et al. 1998). Antral follicles that are not selected for maturation will not be ovulated and die by 
apoptosis (Hsueh et al. 2000). 
 
Germ cell death 
 Loss of oocytes occurs at several different time periods in germ cell development, and 
much of this death is thought to be due to apoptosis.  In support of this, Coucouvanis (1993) 
found that classic apoptotic germ cell shrinkage and nuclear chromatin condensation were 
present in the murine gonad between 13.5 dpc and PND 1.  Further, Ratts and colleagues (1995) 
showed that between 15.5 dpc and PND 1, dying oocytes from mouse ovaries demonstrated the 
characteristic DNA laddering pattern of apoptosis. 
 Oocyte programmed cell death is not unique to mice and in fact, appears to be conserved 
throughout the animal kingdom.  In hermaphroditic nematodes, oocytes arrested in pachytene 
undergo apoptosis, resulting in a 50% loss of germ cells (Gumienny et al. 1999).  Furthermore, 
Drosophila  produce prospective germ cells in cysts, known as cystocytes, that serve a 
supportive nurse cell function and die just after dumping their cytoplasmic contents into the 
oocyte.  Moreover, as in mouse and human, Drosophila germ cells undergo programmed cell 
death if they do not reach the developing gonad (Pritchett et al. 2009). 
 Neither the function, nor mechanism, by which mammalian germ cells die is understood.  
Apoptosis occurs in many systems throughout the course of development; however clues to germ 
11 
 
cell death mechanisms and functions may come from the nervous and immune systems.  In both 
systems, cells are overproduced during early neuro- and lymphogenesis  and are subject to at 
least two different waves of apoptosis both in utero and postnatally (Elmore 2007).  Numbers of 
developing neurons are limited by the availability of neurotrophic factors during the proliferative 
period and post-mitotically.  Not only does this process determine the number of neurons, but it 
also establishes appropriate, functional synaptic connections between neurons (Yuan & Yankner 
2000).  Similarly, young lymphocytes are overproduced and removed by limited cytokine 
availability.  Once initial cell numbers are reduced, further apoptosis occurs to generate 
lymphocytes with functional antigen receptors possessing the exact level of responsiveness 
needed for a working immune system (Opferman 2008).  As in immune and nervous systems 
where cell numbers rapidly decline and modules of functionality are assembled, oocyte numbers 
are sharply reduced and placed into functional units, the ovarian follicles. 
 Although the mechanisms in these other systems are still uncertain, involvement of 
various growth factors/cytokines, members of the B-cell Leukemia (BCL2) family and death 
receptor pathways have been established. One model for the role of perinatal oocyte apoptosis is 
to break down cysts, consequently allowing the remaining germ cells to form primordial follicles 
(Pepling & Spradling  2001).  It is unknown at this time which mechanisms are controlling the 
apoptosis of germ cells, but it is our hypothesis that like neurons and lymphocytes, death is 
controlled by growth factor signaling and its subsequent regulation of intrinsic and extrinsic 
apoptotic pathways. 
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Extrinsic regulation of oocyte apoptosis 
 Programmed cell death occurs through two distinct mechanisms, the extrinsic and 
intrinsic pathways.  Extrinsically, death receptors can initiate the death program in cells. Death 
receptors belong to the Tumor Necrosis Factor(TNF)/Nerve Growth Factor (NGF) receptor 
superfamily, which consists of 26 known members. Some of the more well-studied members 
include: TNFR1, TRAIL-R1, TRAIL-R2, DR-3 and FAS.  Each of these receptors is 
characterized by a unique cytoplasmic region consisting of approximately 80 residues, known as 
the death domain (DD) (Lavrik et al. 2005).  Once a receptor has been activated by its ligand, it 
homotrimerizes, and recruits an adaptor protein and Caspase-8 to the DD.  The recruitment of the 
Death-Inducing Signaling Complex (DISC) to the DD results in cleavage of Caspase 8 and the 
initiation of two possible death signaling pathways  (Schmitz et al. 2000), either direct 
amplification of a caspase cascade, or the cleavage of BID (a BCL2 family member) and 
activation of the apoptosome through the mitochondrial pathway, demonstrating cross-talk 
between the pathways (Scaffidi et al. 1998). 
 Several studies have examined the expression (Guo et al. 1994) and role of FAS receptor 
signaling in spermatogenesis and oogenesis (Sakata et al. 2003, Moniruzzaman et al. 2007, Kim 
et al. 2009).  Mice express FAS at five weeks of age in oocytes, but not granulosa cells, and the 
receptor has been found to be functional in both male and female gametes (Guo et al. 1994, 
Sakata et al. 2003).  In Kit/Fas double knockout mice, the loss of the FAS receptor rescues the 
loss of germ cells seen in the Kit knockout alone, implicating the FAS pathway in germ cell 
apoptosis in Kit deficient mice (Moniruzzaman et al. 2007).  Recently, FAS knockout ovaries 
were analyzed for oocyte death, and the percent of oocytes staining positive for TUNEL was 
significantly lower in the knockout mouse (Kim et al. 2009).  However, the number of oocytes 
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per section was not different between the control and FAS deficient ovaries.  This could be 
attributed to the timing of analysis; PND2 may be too early a time point to see a significant 
difference in cell numbers since PND2 and PND3 are the days of peak ooocyte death (Pepling & 
Spradling  2001). 
 Another death receptor pathway involved in perinatal oocyte death may be Tumor 
Necrosis Factor. When PND 1 rat ovaries were treated with an antibody to TNF in organ culture, 
there was an increase in germ cells (Morrison & Marcinkiewicz  2002).  In the same study, when 
PND 1 ovaries were exposed to exogenous TNF in culture, there was a reduction in oocyte 
numbers.  Supporting this, Greenfeld et al. (2007) found that treating newborn mouse ovaries 
with exogenous TNF in culture resulted in a marked reduction in the number of oocytes present.  
However, a deletion of either TNFR1 or TNFR2 in vivo did not result in any differences in germ 
cell numbers, making it unclear how important TNF signaling is to perinatal in vivo ovarian 
development. 
 
Intrinsic regulation of oocyte apoptosis and the BCL2 family 
 Intrinsically, apoptosis is regulated by factors that ultimately change the permeability of 
the outer mitochondrial membrane.  This can occur because of a negative signaling event such as 
withdrawal or absence of growth factors, cytokines or hormones, or through a positive signaling 
event like exposure to radiation, hypoxia, toxins or viruses.  Once the mitochondrial membrane 
has been compromised, the apoptotic factor Cytochrome C can be released into the cytoplasm.  
Cytochrome C then joins with Procaspase 9 and Apaf-1 to form the apoptosome.  At this point 
the caspase cascade commences and cell death quickly ensues. 
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 Proteins known to regulate the mitochondrial cell death pathway are members of the 
BCL2 superfamily.  This family can be divided into two discrete groups of molecules, those that 
are pro-apoptotic (BAX, BAK, BAD, BID) and those that are anti-apoptotic (BCL2, BCLX, 
MCL1) (Kim and Tilly 2004).  BCL2 molecules share some degree of protein homology as each 
protein contains at least one BCL2 homology (BH) domain, BH3.  Anti-apoptotic BCL2 family 
members share 3-4 BCL2 homology (BH) domains, while the pro-apoptotic members either 
share only domains 1-3 or are part of the BH3-only group of proteins.  These domains are 
thought to be crucial for protein-protein interactions between family members (Chao & 
Korsmeyer 1998).  Generally, members such as BAX reside either in the cytoplasm and 
translocate to the mitochondria on activation or reside in the mitochondrial membrane itself and 
form pores in the outer mitochondrial membrane, releasing Cytochrome C.  This can be 
prevented by heterodimerization with anti-apoptotic members like BCL2, which typically reside 
in the cytoplasm until activated. Figure 1.4 represents general BCL2 family mediated apoptosis 
and survival.  Overall, it is thought that BH3-only proteins “sense” the death signal (i.e. 
withdrawal of growth factor) and either activate pro-apoptotic BCL2 proteins directly, or inhibit 
the ability of anti-apoptotic BCL2 to heterodimerize with the death-inducing members, resulting 
in apoptosis (Walensky  2006).  Ultimately, the balance of anti-apoptotic members with pro-
apoptotic members determines cell death or survival (Danial  2007). 
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 The BCL2 family member BCL2 –associated X protein, BAX, has been implicated in the 
establishment of the primordial follicle pool.  At PND 42, deletion of Bax in the murine ovary 
tripled the number of primordial follicles present when compared to wild type mice (Perez et al. 
1999).  However, no differences in the number of primordial or primary follicles were observed 
at PND 4 in the Bax null strain.  Oocytes found in cysts were not included in the total germ cell 
count at PND 4 and this may be why no differences were noted. In a later study, it was 
determined that mutation of the bax gene resulted in an increased number of oocytes, and 
significantly more oocytes were found in germ cell cysts at 13.5 dpc, 15.5 dpc, PND 4, and PND 
7 (Greenfeld et al. 2007).  Both studies implicate BAX as being important in determining oocyte 
number in the ovary, but the role of BAX in the perinatal wave of apoptosis is still unsolved.  
One puzzling finding in the Greenfeld study was that although the pro-death protein, BAX, was 
absent from ovaries, oocytes continued to stain positively for TUNEL between 15.5 dpc and 
PND 4.  This may indicate a redundancy with another Bcl2 family member, such as BCL2 
homologous antagonist killer (BAK).  Bak knockout mice do not display a phenotype, however 
when combined with a Bax deletion, multiple tissues are affected, resulting in perinatal death 
(Lindsten et al. 2000).  This effect is more severe than either BAK or BAX elimination alone.  
Unfortunately, although female mice were reported to have imperforate vaginal canals, no 
observations or reports have been made on the ovaries of Bax/Bak double mutants.  No 
information is available on how double deletion of these pro-apoptotic proteins affects perinatal 
oocyte survival. 
 Anti-apoptotic BCL2 family members may also regulate oocyte apoptosis.  Recently, the 
BCL2 protein has been identified as a possible regulator of germ cell death in female mice.  Both 
overexpression and knockout of the Bcl2 gene alter ovarian histology.  Overexpression of BCL2 
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in the mouse ovary resulted in increased numbers of primordial, primary and secondary follicles 
at PND 9 and PND 27, however this difference was resolved by PND 60 (Flaws et al. 2001).   
Additionally, in a Bcl2 knockout model, PND 42 murine ovaries contained follicles devoid of 
oocytes and had fewer primordial follicles (Ratts et al. 1995).  While these studies do indicate a 
role for the BCL2 protein in follicle development and germ cell death, further research needs to 
be done to determine if BCL2 exerts its effect specifically during the perinatal wave of apoptosis.  
Another anti-apoptotic member of the BCL2 family, BCL2-like Protein 1 (BCLX), may play a 
role in ovarian germ cell death.  Transgenic Bcl-x knockdown mice display 94% fewer 
primordial follicles at PND 9 than controls (Rucker et al. 2000).  At 13.5 dpc, the number of 
oocytes was markedly reduced, indicating a role for BCLX in embryonic germ cell death.  In 
contrast, utilizing the same transgenic mice, Riedlinger and colleagues (2002) found no 
differences in ovarian follicle numbers in mice at 5 weeks or 3 months of age. Finally, the anti-
apoptotic protein Myeloid Cell Leukemia Sequence 1 (MCL1) is expressed in human ovary 
during the time of primordial follicle formation, but no work has been done to demonstrate a role 
for this protein in oocyte survival at that time (Hartley et al. 2002). 
 
KIT signaling in the ovary 
 Apoptosis can be controlled by molecules that may up- or down-regulate BCL2 family 
members, or molecules that activate BCL2 independent pathways.  For example, the processes of 
erythropoiesis, lymphopoeisis, mast cell generation, gametogenesis and melanogenesis all 
depend of the binding of KIT ligand (KITL), also known as Stem Cell Factor (SCF) to its 
receptor, KIT, for regulation of cell survival (Roskoski 2005). As a Receptor Tyrosine Kinase 
(RTK), KIT has the ability to activate at least three different pathways that are known be 
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involved in cell survival and proliferation: RAS/MAP kinase, Phosphoinositide 3 Kinase (PI3K) 
and Janus Kinase-Signal Transducer and Activator of Transcription JAK-STAT (Schlessinger  
2000). 
 Much of what is known about KIT and KITL function in the ovary comes from mice 
mutant for the W and Steel loci, respectively.  Mutations at either locus are responsible for both 
male and female sterility, as well as severe anemia and white coat color (Little & Cloudman 
1937; Huang et al. 1992).  Numerous studies using various gene deletions, knockdowns and 
organ culture systems have attempted to dissect when and where KIT signaling is important in 
the ovary. 
 Studies first discovered that KIT was imperative for oocyte survival at various stages. 
Early on, KIT signaling is important in proliferation and survival of the primordial germ cells as 
they migrate to the genital ridge (Huang et al. 1993).  Expression of KITL was found in the 
somatic cells lining the migratory pathway from hindgut to potential gonad, and the expression 
increased nearer the genital ridge, while the KIT receptor was expressed on germ cells (Matsui et 
al. 1990, Keshet et al. 1991). KIT signaling is also important to later follicle development after 
birth.  Using an injection of the KIT antibody ACK2, Yoshida et al.(1997) found that both 
primordial and antral follicle survival was attenuated when KIT signaling was blocked. Reynaud 
and colleagues (2001) demonstrated that KITL and KIT were also essential for follicular 
survival, protecting pre-antral follicles from apoptosis.  The exact contribution of KIT signaling 
to the survival of oocytes in cysts in later fetal and early neonatal development is unclear. 
Yoshida and colleagues (1997) failed to find that KIT plays any role in the survival of oocytes 
before or during primordial follicle formation. In contrast, oocyte death was rescued by three 
days of KITL treatment in culture between 16.5 and 19.5 dpc (Lobascio et al. 2007).   Further, 
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KITL has been shown to prevent oocyte apoptosis in the neonatal rat ovary (Jin et al. 2005).  In 
this study, the authors used both KITL and ACK2 to demonstrate the necessity of this signaling 
pathway to the survival of both unassembled oocytes and oocytes found in primordial follicles. 
 Processes such as proliferation and differentiation can also be controlled by the KIT 
system.  Matusi and colleagues found that culturing 11.5 dpc PGCs with recombinant KITL 
greatly increased their proliferation, especially when in the presence of Leukemia Inhibitory 
Factor (Matsui et al. 1991).  There is evidence demonstrating that KIT signaling may both 
enhance and halt meiotic progression. When 13, 14 and 17 dpc ovaries were cultured with a 
combination of three different growth factors including KITL, they progressed to the pachytene 
stage of meiosis more quickly, suggesting the KITL/KIT system may play a role in regulating 
meiotic progression (Lyrakou et al. 2002). However, because KIT expression is reported to cease 
by 14.5 dpc and because the authors used a three growth factor cocktail in this experiment, it is 
unclear whether KITL would actually regulate meiosis after 13.5 dpc (Manova et al. 1990).  It 
has also been reported that KITL actually maintains diplotene arrest in developing follicles.  
Ismail (1996), cultured 28 day old rat oocytes primed with gonadotropins in media containing 
KITL and found that progression to metaphase II of meiosis was transiently blocked.   Further, 
injecting oocytes within oocyte-cumulus cell (OCC) complexes with antisense oligonucleotides 
to the KIT receptor significantly reduced germinal vesicle breakdown, one of the key signs of 
meiotic resumption (Ismail et al. 1997).  In the same study, when OCCs were exposed to 
Luteinizing hormone the number of KITL transcripts decreased specifically in the cumulus cells, 
indicating that a reduction in KITL in the cells closest to the oocyte may be responsible for the 
progression of meiosis. 
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 KIT signaling has also been shown to be important to developing follicle transitions. 
Steel
panda
 mutant mice, a KITL hypomorph, secrete only a small amount of KITL and have a 
complete block on follicle development at the primordial follicle stage (Huang et al. 1993).  
Follicles in these ovaries remain as primordial follicles that never transition to primary follicles, 
resulting in sterility. Supporting this, primordial follicle development is blocked when ACK2 
antibody is injected into newborn mice (Yoshida et al. 1997).  Likewise, when KIT signaling is 
activated by adding recombinant KITL to rat ovary organ culture, the primordial to primary 
follicle transition is significantly enhanced (Parrott & Skinner 1999).  More recent evidence has 
begun to demonstrate reciprocal signaling between granulosa cells and oocytes during the 
primordial follicle transition involving KIT signaling.  Otsuka and Shimasaki (2002) found that 
in the presence of KITL, granulosa cell mitosis increased, indicating an indirect regulation of 
granulosa cell division via the oocyte KIT signal. In the same study, when an antibody to KIT 
was added to culture media, granulosa cell division decreased. 
 Several factors have been suggested to either regulate the expression of KITL or act in 
concert with KIT signaling to induce primordial follicle activation.  BMP15 secretion from the 
oocyte increases somatic cell mitosis, as well as expression of KITL in these cells (Otsuka & 
Shimasaki  2002).  In another study, both granulosa cell derived KITL and oocyte secreted Basic 
Fibroblast Growth Factor (bFGF) were shown to act in synergy to increase the primordial to 
primary follicle transition. Ovaries grown in culture with recombinant KITL in conjunction with 
an antibody to bFGF were unable to promote the primordial to primary transition seen when 
KITL was added alone.  In addition, when exogenous bFGF was added to culture in combination 
with ACK2, the activation of primordial follicle development was again blocked. Analysis of 
mRNA expression at the conclusion of ovary culture with either exogenous KITL or bFGF alone 
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found that addition of bFGF resulted in an increase in KITL transcripts, suggesting bFGF 
regulates expression of KITL during this phase (Nilsson & Skinner  2004). Knockout of another 
growth factor, GDF9, increases ovarian KITL mRNA, implying that this protein may directly 
regulate KITL expression (Elvin et al. 1999). Finally, Leukemia Inhibitory Factor (LIF) was 
found to be expressed in the granulosa cells of newborn rat primordial follicles and when added 
to culture, promoted the primordial to primary transition. Further, granulosa cells cultured with 
LIF expressed mRNA for KITL more highly, suggesting that LIF and KITL may synergistically 
regulate primordial follicle activation (Nilsson et al. 2002).  It is possible that some of these 
KITL regulatory pathways are also working during primordial follicle formation. 
 Later, the KIT/KITL system is involved in the transition from pre-antral to antral follicle.  
By blocking KIT signaling specifically during the time of antrum formation, Yoshida and 
colleagues (1997) were able to disrupt antrum formation.  Further, granulosa cell mitosis was 
greatly reduced, again supporting the notion that KIT signaling at the oocyte regulates 
downstream molecules that communicate directly with surrounding somatic cells (Yoshida et al. 
1997). Similarly, when rat ovaries were subjected to the ACK2 antibody in culture for 14 days, 
gonadotropin induced transition of pre-antral to antral follicles was abolished (Parrott & Skinner 
1999). 
 In addition to examining the function of KIT signaling in oocyte apoptosis, proliferation, 
meiotic progression and folliculogenesis, studies have begun focusing on the mechanisms by 
which KIT is working.  KIT can signal through several different signaling cascades including 
JAK-STAT, PI3K and MAPK (Schlessinger 2000). Of these, PI3K seems to be the likely 
candidate pathway activated downstream of KIT during cyst breakdown. The PI3K pathway acts 
to transform PIP2 to PIP3, which then activates AKT. AKT can then phosphorylate several 
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different molecules including: TSC1 and 2, mTOR, GSK3, FOXO3, p27 or BCL2 proteins. Akt1 
knockout mouse ovaries contain multiple oocyte follicles at PND 25, indicating a role for the 
PI3K pathway in cyst breakdown (Brown et al. 2009). Further, investigations using neonatal rat 
ovaries in culture with an AKT inhibitor downstream of the KIT signal resulted in a decrease in 
phosphorylated FOXO3A and total p27 which was associated with a decrease in oocyte 
apoptosis (Liu et al.  2009). It is not likely however, that FOXO3A is involved in mouse cyst 
breakdown as Foxo3a knockouts demonstrate normal primordial follicle formation (John et al. 
2009). Additionally, although p27 knockout mice show modulation of primordial follicle 
formation, expression of p27 was found to be in the somatic cells surrounding cysts and so is not 
likely activated downstream of AKT in the oocyte during cyst breakdown in mice (Rajareddy et 
al. 2007). Regulation of TSC1/2 and mTOR may be the key PI3K downstream pathway activated 
during cyst breakdown within oocytes. Few studies have examined the role of this pathway in 
follicle development, but it has recently been shown to be important in primordial follicle 
activation in Tsc1 knockout mice (Adhikari et al. 2010). Although conditional knockout lines of 
Tsc1 or PTEN (a negative regulator of PI3K signaling) proteins demonstrate normal primordial 
follicle formation (Adhikari et al. 2010, Reddy et al. 2008), in each study the GDF9 promoter 
was used to drive Cre recombinase expression in the oocyte, and this promoter is not active early 
enough to affect cyst breakdown (McGrath et al. 1995). The p85 subunit of PI3K binds directly 
to tyrosine 719 on KIT, activating the PI3K pathway. Mice with a point mutation at KIT Y719 
demonstrate normal cyst breakdown and even PGC migration during fetal life (Kissel et al. 
2000; John et al.  2009). However, Farini and colleagues (2007) showed that PGC migration was 
dependent on PI3K activity downstream of KIT, contradicting the results of the genetic studies.  
Recently, the scaffolding protein, GAB2 has been shown to bind directly to KIT and activate 
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PI3K signaling, bypassing the need for a direct p85 binding site (Sun et al. 2008).  Sun (2008) 
also showed that a mutation at Y719 downregulated PI3K signaling but did not abolish it. 
Therefore, more work needs to be done to determine the affects of the PI3K pathway in cyst 
breakdown and primordial follicle formation. 
 In addition to examining the function of KIT signaling in follicle formation and 
development, studies have begun focusing on the mechanisms by which KIT affects oocyte 
apoptosis. In the ovary, several BCL2 family members have been implicated in the regulation of 
oocyte survival (Ratts et al. 1995; Perez et al. 1999; Flaws et al. 2001; Hartley et al. 2002). In 
addition, compelling evidence from several studies implicates the PI3K signaling pathway, 
downstream of KIT activation, in regulating BCL2 family members BCL2, BCLX, BAD and 
BAX to promote rat oocyte survival (Jin et al. 2005, Liu et al. 2009).  In human, anti-apoptotic 
MCL1 is expressed during primordial follicle formation (Hartley et al. 2002). This may be a 
more likely candidate BCL2 protein regulated by the PI3K pathway in mouse during follicle 
formation. 
 Both MAPK and JAK-STAT can be activated by KIT, but very few studies have 
examined these pathways during cyst breakdown and perinatal oocyte loss. One study found that 
when newborn rat ovaries were exposed to exogenous KITL in culture, both MAPK and AKT 
were upregulated (Jin et al. 2005) as were anti-apoptotic members of the BCL2 family.  Using an 
inhibitor of the MAPK pathway did not have any effect on BCL2 family member expression or 
oocyte survival. However, primordial follicle assembly was not evaluated in this study and 
therefore the effects of MAPK phosphorylation are unclear.  In other cell types the JAK-STAT 
pathway regulates BCL2 family members (Alvarez & Frank 2004), but no evidence to date has 
shown that this is functional in the oocyte during the perinatal wave of apoptosis.  Although the 
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work on the PI3K pathway downstream of KIT in the ovary has been extensive, clear evidence 
of a role for this pathway in cyst breakdown and germ cell survival during the perinatal apoptotic 
wave does not exist. Further, few studies have examined the effects of KIT mediated MAPK or 
JAK-STAT phosphorylation during cyst breakdown. 
Conclusion 
 Cyst breakdown and oocyte death have become more extensively studied in recent years.  
However, there has not been a clear understanding of the factors that control these processes, as 
no study to date has isolated a mechanism that results in a complete block on cyst breakdown or 
germ cell apoptosis.  Many growth factors and a few death pathways have been identified as 
playing a partial role in the perinatal wave of follicle formation and oocyte survival, but more 
work needs to be done to determine which molecules will have the largest impact on these 
processes.  Here, we describe two different investigations involving BCL2, MCL1 and KIT and 
their role in both neonatal oocyte survival and primordial follicle formation. 
 Very little work has been done on the BCL2 family and oocyte survival during the 
perinatal wave of apoptosis, and we sought to elucidate a role for an anti-apoptotic BCL2 family 
member in the neonatal ovary.  Given that overexpression of BCL2 has been shown to increase 
the ovarian reserve and that BCL2 knockout results in a reduction of primordial follicles in adult 
ovaries, we hypothesized that this protein may be responsible for determining oocyte numbers at 
the time of birth (Ratts et al. 1995, Flaws et al. 2001).  Additionally, because MCL1 is expressed 
in the human ovary during cyst breakdown and oocyte loss, we postulated that this protein may 
also have a role in oocyte survival (Hartley et al. 2002).  While we found BCL2 to be dispensible 
for early oocyte survival, using an ovary organ culture system, we found MCL1 to be an 
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important regulator of germ cell survival at the time of birth. This work will be presented in 
Chapter 2. 
 Although much literature exists on KIT and later follicle formation, not much has been 
done to examine its role specifically at the time of cyst breakdown. Yoshida and colleagues 
(1997) did not observe any effect of injecting an antibody to KIT on primordial follicle 
formation. Conversely, when growing hamster ovaries in culture with KITL, Wang and Roy 
(2004) found that KIT signaling promoted the formation of primordial follicles from cysts.  To 
clarify the requirement for KIT signaling during cyst breakdown and oocyte death, we used an 
organ culture system to directly inhibit and activate KIT signaling during these processes. Our 
results show that the KITL/KIT system is instrumental in promoting the formation of the 
primordial follicle pool. This work will be described in Chapter 3. 
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CHAPTER 2: 
Role of the Anti-Apoptotic Proteins BCL2 and MCL1 in the Neonatal Mouse Ovary 
2.1 ABSTRACT 
 The mammalian ovarian lifespan is determined at the time of birth through a delicate 
balance of oocyte survival and apoptosis as primordial follicles form, and the mechanism by 
which germ cells die is not understood. We hypothesized that two BCL2 family proteins, BCL2 
and MCL1, may be responsible for regulating neonatal oocyte survival. Previous work has 
shown that BCL2 is important for germ cell survival in adult mouse ovaries, but no work has 
been done to examine its role at the time of birth. To elucidate the effects of BCL2 in the 
neonatal ovary, we examined ovaries of both Bcl2 overexpressing and knockout transgenic mice. 
When compared to wild-type mice, neither Bcl2 overexpression nor abrogation significantly 
altered ovarian histology. Another BCL2 family protein, MCL1, is expressed in human oocytes 
during ovarian development, suggesting a role for MCL1 in oocyte survival. To test this, we first 
examined the expression of MCL1 in the newborn mouse ovary. MCL1 was localized to both 
oocytes and somatic cells during primordial follicle formation. Subsequently, we used an in vitro 
organ culture system to identify a role for MCL1 in oocyte survival. We found that inhibition of 
MCL1 with an antibody to MCL1 in culture resulted in a reduced number of germ cells and an 
increase in cyst breakdown. Our data demonstrate that while BCL2 is not likely involved in 
perinatal oocyte survival, MCL1 may be an important regulator of the ovarian primordial follicle 
reserve. 
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2.2 INTRODUCTION 
 The endowment of germ cells in a mammalian female is determined at the time of her 
birth, and the process that establishes this reserve is complex. In mouse, germ cells arrive at the 
potential gonad at approximately 10.5 days post coitum (dpc) and begin to divide rapidly by 
mitosis until 13.5 dpc (Peters 1970). Due to incomplete cytokinesis, the oogonia remain 
connected by intercellular bridges, forming germ cell cysts (Pepling & Spradling 1998). Once 
mitosis has ended, oogonia enter meiosis, proceed through the stages of prophase I and 
subsequently arrest in the diplotene stage beginning at 17.5 dpc. Germ cells, now known as 
oocytes, become separated from each other as cysts begin to break down and individual oocytes 
become surrounded by granulosa cells, forming primordial follicles. Cyst breakdown and follicle 
formation are gradual, lasting until postnatal day (PND) 5 (Borum 1961, Menke et al. 2003). 
Coincident with cyst breakdown is a large loss of germ cells, and at the end of this process only 
about one-third of the initial endowment of oocytes remains (Pepling & Spradling 2001). How 
and why oocytes are selected for either death or survival remains a mystery. 
 Loss of oocytes occurs at three different time periods in germ cell development, but in all 
cases, this death is thought to be due to apoptosis (Pepling & Spradling 2001, Coucouvanis et al. 
1993, Ratts et al. 1995). Members of the B-cell Lymphoma 2 (BCL2) family of proteins are 
known regulators of apoptosis and can be divided into two discrete groups of molecules, those 
that are pro-apoptotic (BAX, BAK, BAD, BID) and those that are anti-apoptotic (BCL2, BCL-X, 
MCL1) (Danial 2007). BCL2 molecules share some degree of protein homology as each protein 
contains at least one BCL2 homology (BH) domain, BH3. These domains are thought to be 
crucial for protein-protein interactions between family members and it is the interactions and 
balance of family members that determine cell fate. BCL2 and the other anti-apoptotic family 
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members have 3 to 4 BH domains as well as a transmembrane domain. Some pro-apoptotic 
members such as BAX share this structure while others contain only the BH3 domain. 
 BCL2 and other anti-apoptotic BCL2 family proteins bind to pro-apoptotic BCL2 family 
members such as BAX at the mitochondrial membrane, keeping them inactive (Boumela et al. 
2011). When activated, BAX homodimers form serving as pores allowing mitochondrial 
Cytochrome C to enter the cytoplasm. Cytochrome C associates with Caspase 9 and Apoptotic 
Peptidase Activating Factor 1 (APAF1) forming the apoptosome and activating downstream 
effector caspases which in turn activate apoptosis (Fuchs & Steller 2011). 
 A role for several BCL2 family proteins has been established in germ cell survival. 
Knockout of the pro-apoptotic Bax gene in the murine ovary resulted in an increased number of 
oocytes in fetal, neonatal, and adult mouse ovaries (Perez et al. 1999, Greenfeld et al. 2007). The 
anti-apoptotic protein, BCL2, has been identified as a possible regulator of germ cell death in 
female mice, as both overexpression and knockout of the Bcl2 gene alter ovarian germ cell 
numbers (Ratts et al. 1995, Flaws et al. 2001). Additionally, Hartley and colleagues (2002) 
found that the anti-apoptotic Myeloid Cell Leukemia Sequence 1 (MCL1) protein was expressed 
in human oocytes during the time when primordial follicles are forming.  MCL1 has a structure 
similar to BCL2 with 3 BH domains and a transmembrane domain (Danial  2007).  MCL1 is also 
believed to function in a manner similar to BCL2 blocking function of proapoptotic family 
members. 
 Although studies on Bax have determined a role for pro-apoptotic BCL2 family 
members, no research to date has elucidated which anti-apoptotic members are important for 
oocyte survival in the perinatal ovary. Based on observations that BCL2 manipulation alters 
adult ovarian histology and that MCL1 protein is expressed in human fetal ovary, we 
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hypothesize that either BCL2, MCL1 or both proteins may play a role in determining final 
oocyte numbers. Here, we show that neither knockout nor over-expression of BCL2 results in a 
change in germ cell numbers, while inhibition of MCL1 significantly decreases the number of 
oocytes in newborn ovaries. Our findings establish MCL1 as a likely regulator of female 
fecundity.       
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2.3 MATERIALS AND METHODS 
Animals 
 For Bcl2 deletion studies, Bcl2 heterozygous mice were obtained from Jackson 
laboratories. Heterozygotes were bred using timed matings to produce homozygous Bcl2 
knockout mice. The morning after mating, female mice were examined for vaginal plugs and the 
presence of a plug was denoted 0.5 dpc. Pregnant mice delivered at 19.5 dpc (PND 1) and pups 
were sacrificed at PND 1, 4 and 7 and genotyped; ovaries were examined for oocyte number, 
follicle formation, and progression. BCL2 overexpressing mice in an FVB background were 
obtained from Jodi Flaws (Flaws et al. 2001). These mice were generated in the Flaws lab by 
fusing the Bcl2 gene to the Kit promoter, allowing overexpression of the BCL2 protein in 
oocytes. KIT receptor is expressed in dividing primordial germ cells and oogonia but is 
downregulated as the germ cells enter meiosis (Manova & Bachvarova 1991). KIT is upregulated 
in oocytes when they reach the diplotene state of prophase I of meiosis which occurs coincident 
with primordial follicle formation (Manova et al. 1990). Adults were mated using timed matings; 
pups were sacrificed at PND 1, 4 and 7 and ovaries were examined for oocyte number, follicle 
formation and progression. For BCL2 overexpression controls, adult FVB mice were also 
obtained from Jodi Flaws, mated and pups’ ovaries were analyzed at PND 1, 4 and 7. 
 For the MCL1 studies adult male and female C57BL/6 mice were purchased from 
Jackson Laboratories. Adults were bred using timed matings to produce offspring for 
experiments. Pregnant mice delivered at 19.5 dpc (PND 1) and pups were euthanized for either 
in vitro ovary organ culture at PND 1 or immunohistochemistry on 15.5 dpc, 17.5 dpc, PND 1, 3 
or 5. 
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 All mice were housed under 12 hour light/dark cycles, temperatures of 21-22 °C, and had 
free access to chow and water. All animal protocols were approved by the Syracuse University 
Institutional Animal Care and Use Committee. 
Genotyping tissue for Bcl2 knockout studies 
 Tail biopsies were collected from pups generated by mating Bcl2 heterozygotes and lysed 
in 20 µl proteinase K and 180 µl tissue lysis buffer overnight at 65 °C. DNA was extracted using 
the Qiagen DNeasy kit. PCR was run on a program of 30 cycles of 94 °C for 1 minute, 57 °C for 
1 minute and 72 °C for 1 minute. To amplify the wild type allele forward and reverse primers 
(Eurofins MWG/OPERON) 5’-CTT TGT GGA ACT GTA CGG CCC CAG CAT GCG-3’ and 
5’-ACA GCC TGC AGC TTT GTT TTC ATG GTA CAT C-3’ were used. To amplify the 
mutant allele forward and reverse primers 5’-CCG GTT CTT TTT GTC AAG ACC G-3’ and 5’-
CGG CAG GAG CAA GGT GAGAT-3’ were used. 
Antibodies 
 STAT3 (C20) (Santa Cruz Biotechnology) and VASA (Abcam) antibodies were each 
used at a dilution of 1:500 for immunohistochemistry. MCL1 and BCL2 antibodies (Santa Cruz 
Biotechnology) were used at a dilution of 1:100 for immunohistochemistry. TUNEL labeling 
(Intergen) was used to visualize dying cells by immunohistochemistry. Secondary antibodies, 
goat anti- rabbit Alexa 488 and goat anti- rabbit Alexa 568 (Invitrogen), were at a dilution of 
1:200. 
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In vitro Ovary Organ Culture 
 Ovaries from PND 1 female mice were harvested and placed on 0.4 m floating filters 
(Millicell-CM; Millipore Corp) in 0.4 ml culture media consisting of D-MEM/HAM’S F12 
Media (Invitrogen), 0.1% Albumax (Invitrogen), 0.1% BSA (Fisher), 5X ITS-X (Life 
Technologies), 0.05 mg/ml L-ascorbic acid (Sigma) and penicillin-streptomycin (Life 
Technologies) in 4-well dishes (Nunc) as previously described (Chen et al. 2007). A single drop 
of media was placed on each of the ovaries to keep them hydrated. 
 To assess MCL1 function in the ovary, ovaries were cultured for 3 days in either media 
alone, media supplemented with a rabbit polyclonal antibody to MCL1 (S-19, Santa Cruz) in a 
1:100 dilution or media supplemented with IgG (Santa Cruz) in a 1:100 dilution. (n=8 ovaries 
per group). For cell death studies, a second group of ovaries were cultured in control or anti-
MCL1 supplemented media for 2 days (n=8 ovaries per group). At the conclusion of culture, all 
ovaries were prepared for whole-mount immunohistochemistry. 
Immunohistochemistry 
 Ovaries were fixed in 5% EM-grade paraformaldehyde (Electron Microscopy Sciences) 
overnight at 4 °C and stained as previously described (Pepling & Spradling 1998). Whole ovaries 
were labeled with primary antibody overnight, then with anti-rabbit secondary antibody. Nuclei 
were labeled with TOTO-3 or propidium iodide (Invitrogen). A Zeiss LSM 710 Confocal 
Microscope was used to image ovaries. As a control, some ovaries were labeled with only anti-
rabbit secondary antibody. 
 To detect the uptake of MCL1 antibody by live ovarian cells, ovaries were first cultured either in 
control media or in media containing the anti-MCL1 antibody overnight.  Ovaries were then 
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fixed in 5% paraformaldehyde overnight and labeled with anti-rabbit secondary antibody.  
Nuclei were labeled with propidium iodide and ovaries were then imaged. 
Analysis of germ cell cyst breakdown and follicle development 
 For both BCL2 and MCL1 studies, oocytes were labeled with STAT3 antibody, a known 
marker of germ cells and imaged with confocal microscopy (Murphy et al. 2005). For each 
ovary, 2 cores were visualized and counted. A core is a region 135 x 135 µm consisting of 
optical sections at 4 different depths in the ovary each 15-20 µm apart. Thus, for each ovary, 2 
cores were obtained consisting of 4 optical sections per core for a total of 8 optical sections per 
ovary. The number of oocytes found in cysts relative to the total number of oocytes was 
determined for each ovary by analyzing each section and reported as percent single oocytes. In 
order to determine whether oocytes were in cysts or not, for each of the 4 optical sections in a 
core, a z-stack of images each 1 µm apart was obtained with 5 images above the section and 5 
images below the section being analyzed. This allowed us to determine whether an oocyte was 
part of a germ cell cyst above or below the plane of focus. Follicle development was determined 
by counting the number of primordial, primary and secondary follicles present in relation to the 
total number of follicles found and reported as percent primordial, primary or secondary 
follicles. 
Analysis of oocyte numbers 
 Oocyte numbers were determined by counting the number of germ cells found within 
each optical section used for analyzing cyst breakdown and follicle development. The numbers 
were averaged and reported as number of oocytes per section. The number of oocytes per section 
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is used as a proxy for the total oocytes per ovary, therefore, only ovaries that appeared to be of 
similar size and depth were used for counting oocyte numbers. 
Analysis of cell death 
 To visualize dying germ cells, ovaries were first labeled for cell death using the Terminal 
Deoxynucleotidyl  Transferase dUTP nick end labeling (TUNEL)  kit (Intergen) according to 
manufacturer’s specifications and subsequently labeled for the germ cell marker VASA. Ovaries 
were then imaged with confocal microscopy.  In each ovary, 4 optical sections were visualized 
and analyzed by counting the number of TUNEL positive cells relative to the total number of 
cells present. This measure was reported as % TUNEL positive cells per ovary. 
Statistical Analysis 
 A Student’s t-test was used to analyze the effects of BCL2 overexpression in the ovary. 
Effects of blocking MCL1 activity in the ovary and Bcl2 knockout results were analyzed with a 
one-way ANOVA using SPSS statistical software. For all results, p values less than 0.05 were 
significant. 
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2.4 RESULTS 
Expression of BCL2 Protein in Neonatal Ovaries 
 To test the expression of BCL2 protein in neonatal ovaries, ovaries from 15.5 dpc, 17.5 
dpc, PND 1, 3 and 5 mice were harvested, fixed and labeled with an antibody to the BCL2 
protein. Figure 2.1 shows that BCL2 protein is expressed primarily in the cytoplasm of oocytes 
at all ages and appears more strongly expressed in the oocyte at PND 3. Additionally, the protein 
appears to be weakly expressed in the somatic cells.   
BCL2 Overexpression Does Not Alter Oocyte Survival or Cyst Breakdown 
 BCL2 overexpression was previously shown to increase the number of oocytes and 
primordial follicles in mouse ovaries at PND 12 (Flaws et al. 2001), therefore we questioned 
whether this difference originated during the neonatal period. To answer this, we examined 
neonatal ovaries from mice overexpressing BCL2. Ovaries were collected from both BCL2 
overexpressing mice and FVB control neonatal mice at PND 1, 4 and 7, fixed, and labeled with 
the oocyte marker STAT3. Oocyte numbers, cyst breakdown and follicle progression were 
examined. Control and overexpressing mice had an equal number of oocytes per section at PND 
1 and oocyte number decreased at the same rate by PND 4 and 7 (Fig. 2.2A). The drop in 
oocytes/section was statistically significant in both the wild type and overexpressing mice. Cyst 
breakdown was also similar between BCL2 overexpressing and FVB control mice at PND 1, 4 
and 7. Overexpressing mice had 65.0% single oocytes and control mice had 72.1% single 
oocytes at PND 7 (Fig. 2.2B). Again, there was no effect of BCL2 overexpression on follicle 
progression as the percentage of follicles per optical section was similar in  
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control and overexpressing mice (Fig. 2.2C). Figures 2.2D and E show representative confocal 
sections from control and BCL2 overexpressing ovaries. Therefore, it does not appear that 
increasing BCL2 protein in the ovary alters the number of oocytes during the neonatal period. 
Targeted Disruption of Bcl2 Does Not Affect Germ Cell Survival or Oocyte Cyst 
Breakdown 
 To examine whether deletion of ovarian Bcl2 would result in a decrease in the number of 
oocytes in the perinatal period we harvested ovaries from Bcl2 knockout mice and determined 
oocyte numbers, cyst breakdown and follicle progression. No significant differences were seen in 
oocyte numbers at any age among Bcl2
+/+
, Bcl2
+/-
 and Bcl2
-/-
 ovaries (Fig. 2.3A). Similarly, Bcl2 
knockout had no effect on cyst breakdown (Fig. 2.3B). Likewise, deletion of Bcl2 had no effect 
on follicle progression as the percentage of follicles per optical section was similar in control and 
knockout mice (Fig. 2.3C). Again, representative confocal sections from WT and Bcl2 knockout 
ovaries are shown (Fig. 2.3D and E). From these results, BCL2 protein does not seem to play a 
role in determining oocyte survival during the perinatal wave of apoptosis and follicle formation. 
MCL1 is Expressed in Oocytes 
 MCL1 has been shown to be expressed in the human ovary during primordial follicle 
formation, the time when oocyte loss is highest (Hartley et al. 2002), and we questioned whether 
it was also expressed in the neonatal mouse ovary during this  
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same process. We harvested fetal mouse ovaries at 15.5 and 17.5 dpc and neonatal ovaries at 
PND 1, 3 and 5 and fixed and labeled them with an antibody to the MCL1 protein. Figure 2.4A-
C shows the lack of expression of MCL1 at 15.5 dpc. At 17.5 dpc MCL1 expression is detected 
and appears to increase in oocytes between 17.5 dpc and PND 3 (Fig. 2.4D-L).  MCL1 
expression appears to decrease but remains in the oocyte at PND 5 (Fig. 2.4M-O).  From 17.5 
dpc onward, MCL1 expression can also be detected in the somatic cells so it is possible that this 
protein is involved in oocyte or somatic cell survival during the fetal or neonatal time period. 
Inhibition of MCL1 in Organ Culture Reduces Oocyte Survival and Promotes Cyst 
Breakdown in a Dose Dependent Manner 
 Since MCL1 protein was present at PND 1, we wanted to test the effects of blocking the 
protein on germ cell survival. We harvested ovaries at PND 1 and placed them in organ culture 
for 3 days either in control media alone, media supplemented with IgG, or in media 
supplemented with a function-blocking antibody to MCL1 at a dilution of 1:200, 1:100 or 1:50. 
After culture, ovaries were then fixed and labeled for the oocyte marker STAT3 to examine 
oocyte survival, cyst breakdown and follicle progression. Ovaries treated with antibody at 1:200 
show a slight but nonsignificant decrease in the number of germ cells present (8.5 oocytes) from 
control and IgG ovaries (11.8 and 10.7 oocytes; Fig. 2.5A). However, ovaries treated with anti-
MCL1 antibody at 1:100 showed a large decrease in the number of oocytes present after 3 days 
in culture (4.2 oocytes) when compared with both control and IgG treated ovaries (Fig. 2.5A). 
Further loss of oocytes was observed when the MCL1 antibody was used at a dilution of 1:50 in 
culture  
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with treated ovaries containing only 1.1 oocytes (Fig 2.5A).  Interestingly, the decrease in the 
number of oocytes was statistically significant between treatment groups as well, showing a dose 
response effect of the antibody on germ cell survival. After 3 days in culture, cyst breakdown 
was also affected by MCL1 inhibition at both the 1:100 and 1:50 dilutions. Treatment with 1:100 
MCL1 antibody caused a slight increase in cyst breakdown with treated ovaries containing 
85.3% single oocytes. Treatment with 1:50 MCL1 antibody resulted in a statistically significant 
increase with treated ovaries containing 92.8% single oocytes versus 76.7% in IgG treated 
ovaries and 70.7% single oocytes in control ovaries (Fig. 2.5B). Follicle progression, however, 
was unaffected by MCL1 antibody treatment at all three dilutions with control, IgG and anti-
MCL1 treated ovaries demonstrating similar percentages of primordial, primary and secondary 
follicles (Fig. 2.5C). Figures 2.5D and E are representative confocal sections of both control and 
anti-MCL1 treated ovaries.   
Cell Death is Increased When Treated with an Antibody to MCL1 
 To confirm that inhibition of MCL1 indeed resulted in increased oocyte death, we grew 
PND 1 ovaries overnight in organ culture. Ovaries treated with the antibody to MCL1 show a 
statistically significant increase in apoptosis with 14% TUNEL positive cells compared with only 
4.9% in controls (Fig. 2.6A). Representative confocal sections showed a larger number of cells 
labeling with TUNEL in MCL1 treated ovaries when compared with controls (Fig. 2.6B and C). 
These results demonstrate a role for MCL1 in the survival of oocytes and primordial follicle 
formation in the neonatal mouse ovary.   
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Live Cells Are Able to Take Up MCL1 Antibody in Culture 
 To determine whether the MCL1 antibody can access the cytoplasm of live cells, we first 
cultured PND 1 ovaries in either control media alone or in media supplemented with the MCL1 
antibody.  After 24 hours, ovaries were fixed and incubated with the secondary antibody to 
detect the presence or absence of the MCL1 antibody within oocyte or somatic cells.  As 
expected, no MCL1 antibody is detected in control ovaries (Fig. 2.7A).  Figures 2.7B and C 
show the presence of the MCL1 antibody in the cytoplasm of both oocytes and somatic cells.  
Overall, a total of 12.8% of oocytes showed presence of MCL1 antibody within the cytoplasm 
after 24 hours in culture.  The antibody was also found to be present in several granulosa cells, 
however this data was not quantified because the total number of granulosa cells was not 
determined.  This demonstrates the ability of living ovarian cells to take up the MCL1 antibody 
while in culture.     
 
 
 
 
46 
 
 
 
 
 
 
 
 
 
47 
 
2.5 DISCUSSION 
 
 Previous studies have demonstrated a role for BCL2 in establishing and maintaining the 
ovarian reserve (Ratts et al. 1995, Flaws et al. 2001). Flaws et al.(2001) reported an increase in 
the number of primordial follicles when BCL2 was overexpressed in the mouse ovary .  At PND 
8 overexpressors had more primordial follicles than control animals. In addition, by PND 60, the 
Bcl2 transgenic mice have the same number of oocytes as control mice indicating that these extra 
germ cells are not maintained in the adult. Timepoints earlier than PND 8 were not examined so 
it was not known when the difference in oocyte numbers occurred. We hypothesized that this 
difference may be due to a reduction in perinatal oocyte apoptosis. To test this, we analyzed 
newborn ovaries from Bcl2 transgenic mice.  Contrary to our prediction, we did not see an 
increase in the number of oocytes at any time point, indicating that BCL2 protein is not 
important for germ cell survival in early neonatal life. Using Bcl2 knockout mice, Ratts and 
colleagues (1995) found a reduction in the number of primordial follicles at PND 42 but earlier 
timepoints were not examined. However based on the results from our overexpression studies, 
we hypothesized that the reduction found in the previous study would not be a result of increased 
oocyte death during perinatal oocyte apoptosis. To confirm our findings that BCL2 was not 
necessary for oocyte survival in the newborn ovary, we examined neonatal Bcl2 knockout mouse 
ovaries. Again, no significant differences were noted in the number of germ cells between wild 
type and Bcl2 transgenic ovaries. Therefore, we conclude that Bcl2 is dispensable for neonatal 
oocyte survival.   
 Although we found no role for BCL2 in perinatal germ cell survival, previous work 
demonstrated that manipulation of BCL2 protein levels altered ovarian histology, specifically in 
the endowment of primordial follicles (Ratts et al. 1995, Flaws et al. 2001). Recently, Tingen et 
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al.(2009) showed that there is a large loss of pre-pubertal primordial follicles in the mouse ovary 
beginning at PND 6. It is possible that the BCL2 protein is responsible primarily for the survival 
of primordial follicles during this time period. Further studies examining the effects of ablating 
the Bcl2 gene on primordial follicle numbers after PND 6 would shed more light on the 
importance of the protein in pre-pubertal follicle survival.   
 We found that the MCL1 protein was increasingly expressed in murine oocytes from 17.5 
dpc through PND 3, the window of time when primordial follicles form and the greatest amount 
of oocyte death is occurring in the ovary (Pepling & Spradling 2001). Similarly, Hartley et al. 
(2002) reported that MCL1 was expressed in human oocytes during the time of primordial 
follicle formation and oocyte death, suggesting that MCL1 may be conserved across mammalian 
species as an important pro-survival factor for germ cells during the massive germ cell apoptosis 
that accompanies primordial follicle formation. More importantly, it implicates a role for MCL1 
in germ cell survival during cyst breakdown and primordial follicle formation.   
 To test whether the MCL1 protein is important for oocyte survival, we used an in vitro 
organ culture system, because knockout of Mcl1 results in embryonic lethality (Rinkenberger et 
al. 2000). Ovaries cultured in the presence of an antibody to MCL1 demonstrated a decrease in 
the number of oocytes present. This reduction in germ cell numbers was also dose dependent, 
indicating that there is a threshold in the level of MCL1 protein required for survival within 
oocytes. Since MCL1 is a known anti-apoptotic protein (Kozopas et al. 1993), we suspected that 
the reduction in the number of oocytes was due to an increase in apoptosis when MCL1 was 
inhibited in culture. This hypothesis was supported by the increase in TUNEL labeling found in 
ovaries treated with the antibody to MCL1 overnight in culture. We cannot confirm that the 
TUNEL labeled cells are oocytes because they are not labeled with the oocyte marker. We 
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believe that antibody reactivity is lost in dying oocytes and have observed this previously 
(Pepling & Spradling 2001).  MCL1 is expressed in both the oocytes and somatic cells during the 
time of our culture, thus we cannot conclude that the blocking antibody is acting directly on the 
oocytes. The effect could be indirect with the antibody acting on the somatic cells. In any case, 
MCL1 appears to be not only expressed in the murine ovary, but also a key regulator of germ 
cell survival during the time of germ cell loss, cyst breakdown and primordial follicle formation.   
 It is thought that oocyte cyst breakdown may be reliant on germ cell death, as these two 
processes are temporally correlated in the ovary (Pepling & Spradling 2001). Support for this 
idea comes from several studies demonstrating that a delay in cyst breakdown is associated with 
an increase in germ cell number (Chen et al. 2007, Jefferson et al. 2006, Trombly et al. 2009, 
Karavan & Pepling 2012). Greenfeld and colleagues (2007) found that lack of the pro-apoptotic 
BCL2 family protein, BAX, led to a decrease in oocyte death and a reduction in cyst breakdown. 
Likewise, we found that when MCL1 was inhibited and germ cell death increased, the rate of 
cyst breakdown and the percentage of single oocytes also increased. These findings suggest that 
oocyte death may be involved in regulation of cyst breakdown. Alternatively, it is possible that 
the mass germ cell apoptosis caused by MCL1 inhibition left only a few, single oocytes 
remaining. 
 To our knowledge, we are the first to use an antibody in ovarian culture that targets an 
internal cellular protein. Guo and colleagues successfully utilized antibodies targeted to the 
phosphatase of regenerating liver proteins, proteins localized inside the cell, to ablate cancer 
cells (Guo et al. 1994).  Within their study, they were able to demonstrate the ability of both live 
CHO and cancer cell lines to take up the PRL antibodies using a cell culture system.  By 
showing the presence of the MCL1 antibody in the cytoplasm of both oocytes and somatic cells 
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after culture, we have confirmed the findings by Guo and colleagues that live cells can, in fact, 
allow antibodies access to internal portions of the cell in vitro. This is an exciting finding as it 
may lead to the ability to examine more ovarian cell signaling pathways inside of oocytes and 
somatic cells utilizing antibodies that target intracellular proteins.  However, it is still possible 
that the MCL1 antibody is accessing the cytoplasm after fixation due to antibody that may not be 
completely washed out of the tissue prior to membrane permeabilization.  Further experiments 
using immunoprecipitation to detect an MCL1 antibody-MCL1 protein complex would add 
strength to our findings that the antibody appears to cross the cell membrane.       
 The experiments presented here are the first to examine the involvement of BCL2 anti-
apoptotic family members in perinatal oocyte survival and cyst breakdown. We have shown that 
while BCL2 itself does not play a role in early germ cell survival, MCL1 is important for 
preventing oocyte death during cyst breakdown and primordial follicle formation. A conditional 
knockout model of MCL1 should be developed and examined in the future to determine if our in 
vitro organ culture studies reflect what is truly happening in the animal. In addition, how MCL1 
works to affect cell death remains a mystery and should be a focus of future studies. Previous 
work on BCL2 family members has demonstrated that these molecules may heterodimerize with 
pro-apoptotic members such as BOK, BOD, BAK and BAX at the mitochondria (Hsu &Hsueh 
2000, Boumela et al. 2011) or can regulate cellular calcium levels at the endoplasmic reticulum 
to inhibit apoptosis (Bassik et al. 2004). It would be interesting to discover where and how 
MCL1 prevents oocyte death in the ovary during mass germ cell apoptosis. Finally, future work 
needs to identify the molecules that regulate the action of MCL1 in the oocyte to prevent germ 
cell death. New studies revealing the mechanisms by which MCL1 regulates the size of the 
primordial follicle pool would give insight into the establishment and maintenance of the ovarian 
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lifespan and may lead to new discoveries in the regulation of primordial follicle formation and 
fertility.      
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CHAPTER 3: 
KIT signaling regulates primordial follicle formation in the neonatal mouse ovary 
3.1 ABSTRACT 
 The primordial pool of follicles determines the reproductive lifespan of the mammalian 
female, and its establishment is highly dependent upon proper oocyte cyst breakdown and 
regulation of germ cell numbers.  The mechanisms controlling these processes remain a mystery.  
We hypothesized that KIT signaling might play a role in perinatal oocyte cyst breakdown, 
determination of oocyte numbers and the assembly of primordial follicles. We began by 
examining the expression of both KIT and KIT ligand in fetal and neonatal ovaries. KIT was 
expressed only in oocytes during cyst breakdown, but KIT ligand was present in both germ and 
somatic cells as primordial follicles formed.  To test whether KIT signaling plays a role in cyst 
breakdown and primordial follicle formation, we used ovary organ culture to inhibit and activate 
KIT signaling during the time when these processes occur in the ovary.  We found that when 
KIT was inhibited, there was a reduction in cyst breakdown and an increase in germ cell 
numbers.  Subsequent studies using TUNEL and proliferation analyses showed that when KIT 
was inhibited, cell death and somatic cell proliferation were both reduced. Conversely, when KIT 
was activated, cyst breakdown was promoted and oocyte numbers decreased.   Using Western 
blotting, we found increased levels of phosphorylated MAP Kinase and that the survival protein, 
MCL1 was lost when KIT ligand was added to culture. Taken together, these results demonstrate 
a role for KIT signaling in perinatal oocyte cyst breakdown that may be mediated by MAP 
Kinase downstream of KIT.       
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3.2 INTRODUCTION 
 Female fecundity is determined at the time of birth through the establishment of the 
primordial follicle pool, and any aberration in the formation of primordial follicles can result in 
infertility. Follicular formation is tightly regulated and begins during fetal life. After migration to 
the gonad, primordial germ cells (PGCs) divide rapidly but do not complete cytokinesis and are 
connected by intercellular bridges, forming germ cell cysts (Peters 1970, Pepling & Spradling 
1998).  As the germ cells enter meiosis, they cease mitotic division and remain connected until 
they begin to arrest in the diplotene stage of meiosis.  At that time, the germ cells, now called 
oocytes, begin to separate from each other and become surrounded by somatic granulosa cells, 
forming primordial follicles. The process of cyst breakdown and primordial follicle formation 
typically lasts from 17.5 days post coitum (dpc) to post natal day (PND) 5 (Borum 1961, Menke 
et al. 2003).  Concomitant with cyst breakdown is a large loss of germ cells, beginning at 
approximately 17.5 dpc and peaking between PND 2 and 3 of development (Pepling & Spradling 
2001, Pepling et al. 2010).  The mechanisms regulating both perinatal cyst breakdown and 
oocyte survival remain a mystery.  One pathway of interest may be the KIT signaling pathway, 
as it has been previously shown to be important in oocyte survival and follicle development at 
other timepoints. 
 KIT signaling is widely known for its ability to promote cell survival, proliferation and 
differentiation. The receptor, KIT, and its ligand, KIT ligand (KITL) also known as Stem Cell 
Factor (SCF), are encoded by the White Spotting (W) and Steel loci, respectively. Mutations at 
either locus have been studied extensively and result in an array of developmental defects in 
melanogenesis, hematopoiesis and gametogenesis (Roskoski 2005). Signaling depends on the 
binding of KITL to KIT and when bound, the KIT receptor homodimerizes and 
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autophosphorylates at tyrosine residues, attracting and binding downstream signaling molecules 
containing phosphotyrosine binding sites (Roskoski 2005). KIT autophosphorylation is capable 
of activating several downstream cascades, including the JAK-STAT, PI3K, and MAPK 
pathways (Schlessinger  2000).   
 KITL exists in both a soluble isoform and a membrane bound isoform (Roskoski 2005).  
The soluble form (KITL1) is a result of cleavage of the transmembrane portion of the protein, 
allowing the protein to dislodge from the cell membrane.  The membrane bound isoform 
(KITL2) actually lacks exon 6 and therefore, the transmembrane cleavage site, forcing the 
protein to remain anchored at the cell membrane (Ashman 1999). The exact function of each 
isoform is not well understood, however it has been reported that KITL2 binding results in more 
sustained KIT signaling (Miyazawa et al. 1995).      
 The KIT pathway has been shown to be important for many ovarian functions including 
germ cell survival and migration.  Early studies examining Steel mutant mice demonstrated the 
importance of this signaling pathway in the proper migration of PGCs to the genital ridge. A 
decrease in KITL expression results in PGC migration to ectopic sites and a reduction in germ 
cell proliferation and survival (McCoshen & McCallion 1975, Huang et al. 1992, Huang et al. 
1993). Reynaud and colleagues demonstrated that KITL and KIT were also imperative to later 
follicular survival, protecting pre-antral follicles from apoptosis (Reynaud et al. 2001). Finally, 
ovaries of newborn rats exposed to recombinant KITL in culture had a lower percentage of dying 
oocytes than control ovaries (Jin et al. 2005).   
 Postnatal development of follicles is also dependent on the KIT ligand/KIT system.  After 
birth, the flattened granulosa cells of primordial follicles become cuboidal and proliferate, 
forming the primary follicle. This change from primordial to primary follicle has been shown to 
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be dependent on the KIT pathway in several studies. Steel
panda
 mutant mice, a KITL hypomorph 
which produces only a small amount of KITL, show a nearly complete block on the primordial to 
primary follicle transition, leaving a large pool of primordial follicles that cannot develop.  These 
mice are sterile (Huang et al. 1993). In another experiment, when neonatal mice were injected 
with the KIT neutralizing antibody, ACK2, the transition from primordial to primary follicle was 
severely blocked (Yoshida et al. 1997). Conversely, when exogenous KITL was added to 4 day 
old rat ovaries in culture, there was a significant increase in developing primordial follicles 
(Parrott & Skinner 1999). These experiments demonstrate the importance of KIT signaling in 
primordial follicle development, and studies have begun to describe an involvement of the KIT 
signaling pathway in an oocyte-granulosa cell feedback loop. During the primordial to primary 
transition, KIT activation at the oocyte regulates other molecules downstream that affect 
granulosa cell division. Otsuka and Shimasaki (2002) found that in the presence of KITL, 
granulosa cell mitosis increased, indicating an indirect regulation of granulosa cell division via 
the oocyte KIT signal. In the same study, when an antibody to KIT was added to culture media, 
granulosa cell division decreased.   
 KIT signaling is also important in a subsequent stage of follicle development, the 
transition from preantral to antral follicle. As the granulosa cells of primary follicles divide to 
produce multiple layers, a secondary or preantral follicle is formed. These preantral follicles 
eventually gain a fluid filled space, and are then classified as antral follicles. Yoshida and 
colleagues (1997) were able to block the transition from the preantral to the antral follicle stage 
by ACK2 antibody injection. Similarly, when ACK2 was used to block KIT signaling in rat 
ovary culture, a block on gonadotropin induced preantral follicle development was seen (Parrott 
& Skinner 1999).   
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 Although much evidence exists for the role of KIT signaling in ovarian development, the 
contribution of KIT signaling to primordial follicle formation in later fetal and early neonatal 
development is unclear. In hamster, KIT signaling has been shown to promote cyst breakdown 
and primordial follicle formation in vitro (Wang & Roy 2004).  However, using an injection of a 
KIT antibody, Yoshida et al. (1997), failed to find any role for KIT in primordial follicle 
formation in newborn mouse ovaries.  Since KIT is directly involved in, and important to, early 
survival of oocytes and subsequent postnatal development of follicles, we hypothesized that this 
pathway might also regulate the formation of primordial follicles from oocyte cysts. In the 
current study we took advantage of an organ culture system to directly inhibit and activate KIT 
signaling in fetal ovaries, when cyst breakdown and follicle formation begin. Our results 
illustrate the importance of this pathway in the establishment of the primordial follicle pool.  
 
 
 
 
 
 
 
 
 
 
 
 
57 
 
3.3 MATERIALS AND METHODS 
Animals 
 All C57BL/6 mice were purchased from Jackson Laboratories.  Adult male and female 
mice were mated utilizing timed matings, and females were checked for the presence of a vaginal 
plug the following morning. The presence of a vaginal plug was denoted 0.5 dpc of pregnancy.  
Pregnant mice were euthanized on either 17.5 dpc for organ culture experiments or 16.5, 17.5 
and 18.5 dpc for immunohistochemistry.  Otherwise, pregnant dams gave birth at 19.5 dpc (PND 
1) and pups were euthanized at PND 1 and 3 for immunohistochemistry.   
 All mice were housed under 12 hour light/dark cycles, temperatures of 21-22 °C and had 
free access to chow and water. All animal protocols were approved by the Syracuse University 
Institutional Animal Care and Use Committee.   
 
Antibodies 
 For immunohistochemistry, STAT3 (C-20) antibody (Santa Cruz Biotechnology) was 
used at a dilution of 1:500, KIT (C-19) and Stem cell factor (G-19) antibodies (Santa Cruz 
Biotechnology) were used at a dilution of 1:100, VASA antibody (Abcam) was used at a dilution 
of 1:250 and cleaved PARP antibody (Abcam) was used at a dilution of 1:100.  The secondary 
antibodies, goat anti-rabbit Alexa 488, rabbit anti-goat Alexa 488 and goat anti-rabbit Alexa 568 
(Invitrogen), were at a dilution of 1:200. TUNEL labeling kit (Intergen) was used to visualize 
dying oocytes and the Ki-67 (Ab-4) antibody (NeoMarkers) was used to assess cell proliferation.  
For Western blotting, AKT 1/2/3 (H-136), phospho-AKT 1/2/3 (Ser473), STAT3 (C-20) and 
phopho-STAT3 (Tyr 705) antibodies (Santa Cruz Biotechnology) were used at a dilution of 
1:1000.  MAPK p44/42 ERK1/2 and Phospho-p44/42 (T202/Y204) antibodies (Cell Signaling) 
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were used at a dilution of 1:1000 for Western blotting.  Additionally, MCL1 antibody (S-19; 
Santa Cruz Biotechnology) was used at a dilution of 1:50 for Western blotting.  
 
In vitro ovary organ culture 
 As previously described ovaries from PND 1 female mice were harvested and placed on 
0.4 µm floating filters (Millicell-CM; Millipore Corp) in 4 well culture dishes (Nunc) with 0.4 
ml culture media consisting of D-MEM/HAM’S F12 Media (Invitrogen), 0.1% Albumax 
(Invitrogen), 0.1% Fraction V BSA (Invitrogen), 5X ITS-X (Life Technologies),0.05 mg/ml L-
ascorbic acid (Sigma) and penicillin-streptomycin (Life Technologies) (Chen et al. 2007). A 
single drop of media was placed on each of the ovaries to keep them from drying out. 
 To assess the role of KIT signaling in the ovary, 17.5 dpc ovaries were cultured for 5 
days in either media alone, media supplemented with a function blocking antibody to KIT, 
ACK2 (e-biosciences) at a 1:100 dilution, media supplemented with recombinant Stem cell 
factor (R&D Systems) at 100 ng/ml or media supplemented with IgG (Santa Cruz) at a 1:100 
dilution. (n=8 ovaries per group).  To determine the role of  KIT signaling before PND 1, ovaries 
(n=8 ovaries per group) were cultured for 3 days either in control media alone, or in media 
supplemented with ACK2 at 17.5 dpc then switched to control media after 2 days in culture.  To 
determine the importance of KIT signaling at birth, ovaries (n=8) were grown in culture for 5 
days either in control media alone, or in control media at 17.5 dpc then switched to media 
supplemented with ACK2 after 2 days in culture. For cell death and proliferation studies, ovaries 
were cultured in control or ACK2 supplemented media for 3 days (n=8 ovaries per group).  At 
the conclusion of culture, all ovaries were prepared for whole-mount immunohistochemistry.  
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 To determine pathways regulated by KIT signaling, 17.5 dpc ovaries were grown in 
culture for 3 days in either control media or media supplemented with SCF (n=8).  At the 
conclusion of culture, ovaries were prepared for Western blotting.   
 
Immunohistochemistry 
 Ovaries were fixed in 5% EM-grade paraformaldehyde (Electron Microscopy Sciences) 
overnight at 4 °C and stained as previously described (Pepling & Spradling 1998).  Whole 
ovaries were labeled with primary antibody overnight, then with anti-rabbit or anti-goat 
secondary antibody.  Nuclei were labeled with TOTO-3 or propidium iodide.  A Zeiss LSM 710 
Confocal Microscope was used to image ovaries.  As a control, some ovaries were labeled with 
only anti-rabbit secondary antibody. 
 
Analysis of germ cell cyst breakdown and follicle development 
 At the conclusion of cultures, ovaries prepared for immunohistochemistry were labeled 
with STAT3 antibody, a known oocyte marker and imaged with confocal microscopy (Murphy et 
al. 2005). In each ovary, two cores were visualized and counted. A core is a region 512 x 512 µm 
made up of optical sections at 4 separate depths in the ovary 15-20 µm apart. For each ovary, 2 
cores with 4 optical sections were analyzed for a total of 8 sections examined. The number of 
oocytes found in cysts relative to the total number of oocytes was determined for each ovary by 
analyzing each section and reported as percent single oocytes. In order to determine whether 
oocytes were in cysts or not, for each of the 4 optical sections in a core, a z-stack of images each 
1 µm apart was obtained with 5 images above the section and 5 images below the section being 
analyzed. This allowed us to determine whether an oocyte was part of a germ cell cyst above or 
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below the plane of focus. Follicle development was determined by counting the number of 
primordial, primary and secondary follicles present in relation to the total number of follicles 
found and reported as percent primordial, primary or secondary follicles. 
  
Analysis of oocyte numbers 
 To determine oocyte numbers, we counted the number of oocytes found within the 8 
optical sections used for analyzing cyst breakdown and follicle development. The numbers were 
averaged and reported as number of oocytes per section. Only ovaries that appeared to be of 
similar size and depth were used for counting oocyte numbers because the number of oocytes per 
section is an estimate of the total number of oocytes within an ovary. 
 
Analysis of cell death and proliferation 
 To analyze dying cells, ovaries were first labeled with the TUNEL labeling kit (Intergen) 
according to the manufacturers recommendations and then with the oocyte marker antibody, 
VASA.  Ovaries were imaged with confocal microscopy.  In each ovary, 4 optical sections were 
visualized and analyzed by counting the number of TUNEL positive cells relative to the total 
number of cells present.  This number was reported as % TUNEL positive cells per ovary.  For 
proliferation studies, ovaries were first labeled with an antibody to Ki-67, a marker of cell 
division, and subsequently labeled with VASA.  Again, ovaries were imaged with confocal 
microscopy and in each ovary, 4 optical sections were visualized. Each section was analyzed by 
counting the number of Ki-67 positive cells relative to the total number of cells present.  This 
number was reported as % Ki-67 positive cells per ovary.   
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Western blot hybridization 
 17.5 dpc ovaries were grown in culture for 3 days and then homogenized in 10µl of 2X 
sample buffer (10% SDS, Glycerol, 0.1% Bromophenol Blue, 0.5M Tris pH 6.8, and 2-
mercaptoethanol) plus mini-complete protease inhibitors (Roche) per ovary. 2-mercaptoethanol 
was added to extracts at 1/10 of the volume of extract.  Samples were then heated to 95 °C and 
centrifuged at 6000 rpm for 1 minute, separated on a 10% SDS-polyacrylamide gel (BioRad) and 
then electroblotted onto either Immobilon P PVDF (Millipore) or nitrocellulose (BioRad) 
membranes. Membranes were blocked in either PBST (0.05% Tween/PBS) containing 5% 
nonfat milk for AKT, phospho-AKT, MAPK p44/42, STAT3, MCL1 and BAX antibodies or 
TBST (0.05% Tween/TBS) with 5% BSA for phospho-p44/42 and phospho-STAT3 antibodies 
for 1 hour at room temperature. Blots were then incubated with primary antibody diluted in the 
appropriate blocking solution for 1 hour at room temperature.  Membranes were washed 3-6 
times in either PBST or TBST then incubated with secondary antibody diluted in 5% milk 
blocking solution for 1 hour at room temperature. Goat anti-rabbit horseradish peroxidase 
conjugated secondary (Thermoscientific) antibody for the AKT, pAKT, MAPK p44/42, STAT3, 
MCL1 and BAX hybridized blots was used at a dilution of 1:10,000 and at a dilution of 1:15,000 
for phospho-p44/42 MAPK and phospho-STAT3 hybridized blots.  Again, blots were washed 3-
6 times in PBST or TBST and bands were visualized using the Supersignal kit (Pierce) on films.  
Blots were reprobed with anti-mouse GAPDH (1:5000; Santa Cruz Biotechnology) as a control.   
 
Statistical analysis 
 A Student’s t-test was used to analyze cell death and proliferation and studies analyzing 
the effect of blocking KIT in the ovary at different time points.  Effects of ACK2 and 
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recombinant SCF on ovaries cultured for five days beginning on 17.5 dpc were analyzed with a 
one-way ANOVA using SPSS statistical software.  For all results, p values less than 0.05 were 
considered significant.   
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3.4 RESULTS 
Expression of KIT and KITL in the ovary 
 We first tested the expression of both KIT and KITL in the fetal and neonatal ovary to 
determine if KIT signaling could be involved in oocyte survival and follicle formation at the time 
of birth.  To evaluate expression, we harvested ovaries from 16.5 dpc, 17.5 dpc, 18.5 dpc, PND 1 
and PND 3 mice, fixed and labeled them with an antibody to either KIT or KITL. Figure 3.1 
shows the expression of KIT weakly in the cytoplasm of germ cells at 16.5 (A-C) and 17.5 (D-F) 
dpc, and expression at the cell membrane appears to begin in one oocyte at 17.5 dpc.  At 18.5 
dpc (Fig. 3.1G-I) KIT is expressed in a subset of the oocytes in either the cytoplasm or cell 
membrane but becomes pronounced at the cell membrane of oocytes by PND 1 (Fig. 3.1J-L).  
Interestingly, at PND 1 a small subset of cells within a cyst do not express KIT (inset Fig. 3.1L). 
KIT protein appears to be similarly expressed at PND 3 although it may be less pronounced at 
the membrane (Fig. 3.1M-O).  To demonstrate that KIT labels germ cells, we used 
immunohistochemistry on PND 1 ovaries and labeled them with an antibody to KIT and to the 
germ cell marker, VASA.  Figure 3.2 shows that KIT labels only germ cells at PND 1 and that 
some oocytes within a cyst do not express KIT.   
 
 
 
 
 
 
 
 
 
64 
 
 
65 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
66 
 
 We also tested for the presence of KITL in fetal and neonatal ovaries.  Figure 3.3A-C 
shows weak expression of KITL in the cytoplasm of germ and somatic cells at 16.5 dpc.  By 17.5 
dpc, KITL appears to accumulate in small areas of some oocytes, which may represent 
expression of the membrane bound isoform of KITL (Fig 3.3D-F).   From 18.5 dpc onward, 
KITL expression remains in the cytoplasm of oocytes and somatic cells (Fig. 3.3G-O) and 
expression appears to increase from PND 1 to 3.   
 Based on previous work showing that KIT signaling was responsible for oocyte survival, 
we hypothesized that the germ cells within a cyst not expressing KIT at PND 1 would be marked 
for apoptosis.  To test this, we double labeled PND 1 ovaries with an antibody to the apoptosis 
marker, cleaved PARP, and the germ cell marker, VASA.  Figure 3.4A-F shows representative 
confocal sections demonstrating that some oocytes expressing KIT and some oocytes not 
expressing KIT are both positive for cleaved PARP.  To quantify that data, we calculated the 
percentage of oocytes in each confocal section labeling with both the KIT and PARP antibodies 
and those that do not label with KIT but are positive for PARP (Fig. 3.4G).  There was not a 
statistically significant difference between these groups.  Thus there does not appear to be a 
correlation between KIT signaling and oocyte survival.   
 
KIT signaling regulates oocyte numbers, primordial follicle formation and cyst breakdown 
 We first hypothesized that KIT signaling might regulate perinatal germ cell numbers by 
increasing oocyte survival for those expressing KIT.  To test this, we harvested 17.5 dpc ovaries 
and placed them in organ culture for 5 days in either control media alone, media supplemented 
with a 1:100 dilution of an antibody to KIT, ACK2, media supplemented with 100 ng/ml of 
recombinant KITL or media supplemented   
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with 1:100 dilution of IgG as a negative control. Surprisingly, we found an increase in the 
number of germ cells present in the ACK2 inhibited ovaries (14.5 oocytes) and a reduction in the 
number of oocytes in KITL treated ovaries (5.8 oocytes) when compared with both control and 
IgG treated ovaries (8.7 oocytes and 8.1 oocytes; Fig. 3.5A).   
 In addition, we found that when KIT signaling was blocked with ACK2, a large reduction 
in cyst breakdown occurred with only 47% single oocytes found, while an increase in cyst 
breakdown was present in KITL treated ovaries which contained 84% single oocytes (Fig. 3.5B).  
These were both statistically different from the control and IgG groups which had 71.1% single 
oocytes and 77.4% single oocytes, respectively (Fig. 3.5B). Finally, both blocking and activating 
the KIT signaling pathway resulted in changes in follicle development. The ACK2 inhibited 
ovaries showed a complete block on follicle progression with 100% of follicles found in the 
primordial stage and 0% found in the primary or secondary stages (Fig. 3.5C).   
 Follicle development was facilitated by the addition of KITL to culture and resulted in 
78% of follicles found at the primordial stage, 21% at the primary stage and 1% at the secondary 
stage (Fig. 3.5C). Normal follicle development, as demonstrated by the control ovaries, showed 
an average of 87% primordial follicles, 13% primary follicles and 0% secondary follicles (Fig. 
3.5C).  Figures 3.5 D and E are representative confocal sections of both control and ACK2 
treated ovaries demonstrating the increase in oocytes and reduction in cyst breakdown found in 
KIT inhibited ovaries. 
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Kit signaling is required for follicle formation before and after birth 
 Yoshida and colleagues (1997) injected female neonatal mice with ACK2 every other day 
beginning on PND1 and found no effect on germ cell numbers prior to PND 5.  Additionally, 
they did not evaluate oocyte cyst breakdown and follicle formation, although they found normal 
numbers of primordial follicles in the ovary at PND 5. We wondered if the discrepancy between 
our results and those findings was a result of the timing of the ACK2 treatment, as cyst 
breakdown has been shown to begin prior to PND 1 (Pepling et al. 2010).  Therefore, we wanted 
to test the effects of inhibiting KIT signaling on cyst breakdown and oocyte number specifically 
before birth to determine if the signal was important for follicle formation at that time.  We 
began by culturing 17.5 dpc ovaries for 5 days either in media alone, or in media supplemented 
with ACK2 antibody for the first two days of culture then in media alone for the remaining 3 
days of culture to test the effects of inhibiting KIT signaling only before birth.  Figures 3.6 A and 
B show a slight but insignificant increase in oocyte numbers when inhibiting KIT signaling and 
an insignificant decrease in cyst breakdown when ovaries were cultured with ACK2 for only the 
first two days of culture. There was, however, a significant decrease in follicle development 
when KIT signaling was inhibited only for the first two days of culture, with ACK2 treated 
ovaries containing 96% primordial and 4% primary follicles compared to 87% primordial and 
13% primary in control ovaries (Fig. 3.6C).   
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These data suggest that KIT signaling has either no effect on cyst breakdown or oocyte numbers 
before birth, or that both were affected but  rescued by removing the KIT antibody from culture 
and allowing treated ovaries to grow in plain media for the remaining 3 days of culture. 
 To better clarify the affect of blocking KIT signaling before birth, we decided to place 
17.5 dpc ovaries in culture and treat with ACK2 antibody again for the first two days, but this 
time culture them only an additional day in plain media. A length of three days of culture was 
chosen because the final day would correspond to PND 2, the time when germ cell death peaks 
and cyst breakdown is well underway (Pepling & Spradling 2001).  As shown in Figure 3.7A, 
there was a slight but insignificant increase in the number of germ cells present in treated 
ovaries.  However, cyst breakdown was greatly reduced with ACK2 treated ovaries containing 
only 49% single oocytes while control ovaries had 69% single oocytes (Fig. 3.7B).  Finally, 
follicle development was inhibited when KIT signaling was inhibited.  Figure 3.7C shows that 
ACK2 treated ovaries had 99% primordial and 1% primary follicles and control ovaries had 94% 
primordial and 6% primary follicles.   
 
Kit signaling is important for follicle formation after birth 
 Since cyst breakdown is a continuous process lasting from approximately 17.5 dpc to 
PND 5, we wanted to determine whether KIT signaling was still important for follicle formation 
after birth (Pepling et al. 2010).  To test this, we cultured 17.5 dpc ovaries for 5 days in either 
control media alone, or control media for the first two days of culture and then in ACK2 
supplemented media for the remaining 3 days.   
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 While there was a only a slight but insignificant increase in the number of oocytes in the 
ACK2 treated ovaries (9.8 oocytes) when compared with controls (8.2 oocytes; Fig. 3.8A), cyst 
breakdown was significantly reduced with ACK2 treatment (Fig. 3.8B) with inhibited ovaries 
having 59.1% single oocytes and control ovaries containing 77% single oocytes.  
 
Cell death and proliferation are modulated by KIT inhibition 
 Our results showed that KIT signaling is important for regulating cyst breakdown and 
germ cell numbers. Upon KIT inhibition in the ovary, we found a substantial increase in the 
number of oocytes present (Fig. 3.5A). It is possible that the increase in the number of germ cells 
was either due to an increase in oocyte proliferation or a decrease in cell death.  It is generally 
thought that oocytes do not proliferate after fetal life, but this is controversial, and manipulation 
of Activin in neonatal mouse ovaries has been show to increase germ cell proliferation (Johnson 
et al. 2005, Bristol-Gould et al. 2006). To examine the origin of this finding, we placed 17.5 dpc 
ovaries in organ culture for 3 days, ending on the day of peak germ cell death (Pepling & 
Spradling 2001), to assess both cell death and proliferation in the ovary when KIT signaling was 
inhibited. Ovaries were either grown in control media alone, or in the presence of the ACK2 
antibody for 3 days.  At the conclusion of culture, ovaries were fixed and assessed for cell death 
using a TUNEL assay or assessed for cell proliferation using a Ki-67 assay. Ki-67 is a protein 
that expressed only in dividing cells, and is absent in cells that are quiescent.  Ovaries that were 
treated with the KIT inhibitor consisted of fewer dying cells and had only 2.3% TUNEL positive 
cells compared to 8.0% dying in controls (Fig. 3.9A).  Figures 3.9B and 3.9C are  
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representative confocal sections of a control and ACK2 inhibited ovary showing fewer TUNEL 
positive cells in ACK2 treated ovaries.    
 Figure 3.10A shows the effect of ACK2 on cell proliferation in the ovary. We 
hypothesized that either oocyte numbers increased when KIT signaling was inhibited due to 
increased germ cell proliferation, or that KIT may be regulating cyst breakdown by controlling 
somatic cell proliferation as demonstrated in rat ovary by Otsuka and Shimisaki (2002).  
Interestingly, we found that when KIT signaling was inhibited granulosa cell proliferation 
decreased. The representative confocal sections in 3.10B and C are of a control and ACK2 
treated ovary labeled with Ki-67, showing the KIT inhibited ovary containing fewer proliferating 
granulosa cells. These data point to the regulation of a molecule downstream of KIT in the 
oocyte that is involved in communication with granulosa cells.    
 
KITL activates the MAP Kinase pathway 
 
 Kit signaling can activate several different pathways downstream of the receptor, and we 
wondered which of these pathways might be involved in cyst breakdown. To evaluate the 
downstream signaling pathway activated by KIT signaling during cyst breakdown, ovaries were 
cultured for 3 days in either control media alone, or in media supplemented with recombinant 
KITL to activate KIT signaling.  At the conclusion of culture, ovaries were prepared for Western 
blotting and extracts were probed for total AKT, MAPK and STAT 3 as well as the 
phosphorylated forms of these proteins.  Figure 3.11 shows that both control and KITL treated 
ovaries contain similar levels of total AKT, STAT3 and MAPK proteins.  Phosphorylated AKT 
and STAT3 levels were also  
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comparable between control and KITL ovaries. KITL treatment did, however, increase 
phosphorylation of MAPK, indicating that KITL activates the MAPK pathway downstream of 
the KIT receptor. 
 
MCL1 protein is downregulated by KIT signaling   
 The BCL2 family of proteins represents a group of molecules that regulate cell survival.  
Family members such as BCL2 and MCL1 are known to be anti-apoptotic (Kim & Tilly 2004).   
Jin et al. (2005) found that when KIT signaling was activated in newborn rat ovaries, BCL2 was 
increased in response to adding KITL in culture.  However, work from our lab has shown that 
BCL2 is not likely involved in oocyte survival during primordial follicle formation, and that 
MCL1 may play a role in regulating germ cell survival instead (Jones & Pepling, in review).  To 
determine whether MCL1 expression changes in response to KIT signaling, we cultured 17.5 dpc 
ovaries for 3 days in either control media alone, or in media supplemented with recombinant 
KITL.  Ovaries were then prepared for Western blotting and extracts were probed for the protein 
MCL1.  Figure 3.12 shows that when KIT signaling was activated, MCL1 was downregulated, 
indicating that KIT signaling may decrease survival proteins such as MCL1 during cyst 
breakdown.   
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3.5 DISCUSSION 
 Although many studies have shown a role for KIT signaling in ovarian development, 
there is sparse evidence examining its importance in oocyte cyst breakdown and primordial 
follicle formation. Several labs have examined mice mutant for either the Steel or W loci, and 
have found dramatic defects in PGC migration and proliferation that result in a complete loss of 
oocytes by birth (Reith et al., 1990; Huang et al., 1993). These mice are not optimal for 
observing the effects of KIT signaling on cyst breakdown, as cysts do not appear to form in these 
mutant ovaries and there are few oocytes remaining. Other Steel mutants show a decreased 
number of germ cells, but normal primordial follicle formation (Bedell et al., 1995). However, 
these mice continue to secrete low amounts of KITL which may allow for normal cyst 
breakdown and follicle formation.  The present study examines the role of KIT signaling in cyst 
breakdown and primordial follicle assembly using an organ culture system which permits the 
study of KIT signaling specifically at the time these processes are occurring. Using this in vitro 
system, we have elucidated a role for KIT signaling in the fetal and neonatal mouse ovary.  
 We found KIT to be expressed at the oocyte membrane from 17.5 dpc to PND 3.  This 
supports the findings of Manova et al., where Kit RNA was localized to the oocyte beginning in 
just a few cells at 17.5 dpc then increasingly throughout the life of the oocyte (Manova et al. 
1990).  Interestingly, we found that at PND 1 a subset of germ cells within some cysts did not 
express the KIT receptor. This may be due to expression of Activin in those cells. Using 
immunohistochemistry, Coutts and colleagues (2008) found human fetal ovaries expressed KIT 
incongruously in oocyte cysts and those that lacked expression stained positively for Activin.  
We did not test the expression of Activin in our experiments, and therefore cannot say whether 
this same expression pattern is true in mouse ovary.  It would be interesting to test the co-
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expression patterns of KIT and Activin in the mouse ovary to see if this is a conserved pattern in 
mouse. Finally, we found that KITL was expressed in the mouse ovary from 17.5 dpc through 
PND 3 in both oocytes and somatic cells, however the signal for KITL was strongest in oocytes 
at 17.5, but then becomes more evenly distributed between germ cells and granulosa cells by 
PND 3.  It is possible that there is a switch from the KITL membrane bound isoform at 17.5 dpc 
in the oocyte to the soluble form by PND 1, and this switch may take part in regulation of cyst 
breakdown. This could indicate either an autocrine or paracrine signaling mechanism for the 
KIT/KITL system in the developing mouse ovary particularly during follicle formation as 
expression of both components was detected during this time period.   
 Given the positive expression of both KIT and KITL in the mouse ovary, we 
hypothesized that this system would play a role in cyst breakdown and primordial follicle 
formation. To test this, we used in vitro ovary organ culture to both inhibit and activate the KIT 
signaling pathway. When exposed to the KIT inhibiting antibody ACK2, cyst breakdown was 
greatly reduced, and upon activation with recombinant KITL, cyst breakdown was accelerated.  
Our data supports that of Wang and Roy in hamster ovary, where addition of KITL to culture 
promoted the formation of primordial follicles (Wang & Roy 2004).  Alternatively, our results 
contradict earlier findings that suggest that KIT signaling has no effect on follicle formation in 
mouse ovary (Yoshida et al. 1997). Using injections of ACK2 every other day beginning on the 
day of birth, Yoshida and colleagues failed to find that KIT played any role in primordial follicle 
formation, but instead blocked the primordial to primary follicle transition. This study utilized 
newborn mice at PND 1 and, based on work from our lab showing that cyst breakdown begins as 
early as 17.5 dpc, injecting at PND 1 may have been too late a time to affect cyst breakdown and 
follicle formation (Pepling et al. 2010).  Additionally, the every other day injection schedule of 
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ACK2 may have allowed a rescue of cyst breakdown, such that on the days when antibody was 
not given, normal signaling was permitted and primordial follicle formation occurred.   
 In an effort to clarify the differences between our results and those of Yoshida et al., we 
first wanted to test the effect of blocking KIT prior to PND 1 to determine its importance in 
inhibiting cyst breakdown before birth.  To accomplish this, we cultured 17.5 dpc ovaries in the 
presence of ACK2 for 2 days and then allowed the ovaries to continue in culture in control media 
for the remaining 3 days.  To our surprise, ovaries that were treated only on the first two days 
had only a slight decrease in cyst breakdown, but a delay in follicle development remained, 
suggesting a possible rescue of cyst breakdown and follicle formation on the 3 days ovaries were 
not in the presence of the antibody.  To test the idea that follicle formation had been rescued, we 
again cultured 17.5 dpc ovaries in the presence of ACK2 for 2 days but this time only allowed 
them to be cultured for 1 more day before examining them. When removed from culture at the 
earlier time point, ovaries that were treated with ACK2 demonstrated a significant decrease in 
cyst breakdown and primordial follicle formation.  This suggests that follicle formation can be 
rescued when ovaries are allowed to resume normal KIT signaling and in addition, the KIT 
signal is important before birth in cyst breakdown.   
 We also postulated that the KIT signal would continue to be important for cyst 
breakdown at birth, as this process continues from 17.5 dpc to PND 5.  To examine this, we 
cultured 17.5 dpc ovaries first in control media for 2 days and then in ACK2 supplemented 
media for the remaining 3 days.  In support of our hypothesis, we found that cyst breakdown was 
again inhibited, though not as severely as when inhibition was started at 17.5 dpc.  The KIT 
signal appears to be important for cyst breakdown on or after PND 1 in the neonatal ovary. 
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 In our initial experiment, inhibiting KIT signaling in culture for 5 days from 17.5 dpc 
onward also resulted in an increase in the number of oocytes present in the ovary.  We suspected 
that this increase may be due to a decrease in cell death.  Using a TUNEL analysis, we were able 
to quantify the percentage of dying cells in both control and ACK2 treated ovaries and found that 
the inhibited ovaries contained a lower percentage of dying cells.  Although we used an oocyte 
marker to label germ cells, we cannot say for sure that the dying cells are actually oocytes 
because the germ cell marker antibody may lose reactivity in dying cells, therefore dying oocytes 
may not label for Vasa. (Pepling & Spradling 2001).  However, since KIT is expressed only at 
the germ cell membrane and we see an increase in oocyte numbers, it is likely that the decreased 
TUNEL labeling upon KIT inhibition is due to a reduction in oocyte specific death. 
 Alternatively, the increase in germ cell numbers could be due to an alteration in oocyte 
proliferation, although the idea of postnatal germ cell proliferation is controversial.  It has 
generally been accepted that oocytes stop dividing during fetal life and do not resume mitosis, 
however more recent studies have shown oocytes to be proliferating in the newborn mouse 
ovary, challenging the classic dogma (Johnson et al. 2005, Peters, 1969). In addition, we also 
hypothesized that blocking KIT at the oocyte could interrupt communication with the 
surrounding granulosa cells, thus decreasing granulosa cell invasion and/or proliferation. We 
utilized a Ki-67 assay to examine the effects of KIT inhibition on both oocyte and somatic cell 
proliferation.  Although there was no evidence for proliferation of oocytes in any ovaries 
analyzed, there was a significant decrease in the proliferation of granulosa cells when KIT 
signaling was blocked.  This supports the idea that interrupting KIT at the oocyte interrupts some 
downstream molecule that may be involved in communication with the surrounding somatic 
cells, similar to the findings of Otsuka and Shimisaki (2002).  In their study, when soluble KITL 
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was administered to cultured oocyte-granulosa cell complexes, synthesis of DNA was increased 
in the granulosa cells, indicating that activated KIT signaling at the oocyte upregulated granulosa 
cell mitosis through some downstream effector.   
 Much of the work in the ovary has focused on the activation of the PI3K pathway 
downstream of KIT in the oocyte. Upon autophosphorylation of KIT, tyrosine 719 becomes 
phosphorylated and is the primary binding site for the p85 subunit of PI3K and its subsequent 
activation. Mice with a point mutation in the KIT receptor at Y719 are not able to bind p85 and 
therefore cannot activate PI3K downstream of KIT (John et al. 2009).  These mice undergo 
normal cyst breakdown and primordial follicle formation, suggesting the PI3K pathway is not 
involved in primordial follicle formation upon KIT activation (Sun et al. 2008).  In our study, we 
have found that MAPK is activated downstream of KIT upon KITL binding.  We used whole 
ovary protein extracts for Western blot to identify the pathways activated by KIT, therefore we 
cannot conclude that the upregulation of MAPK by KITL is actually occurring in the oocyte. 
Future studies will need to examine the cell types in which MAPK becomes phosphorylated 
when KITL is added to culture, using immunohistochemsitry.  Presumably MAPK 
phosphorylation would be within the oocyte since the KIT receptor is found at the oocyte 
membrane. However KIT signaling appears to increase granulosa cell divison, so the 
phosphorylation of MAPK could be found in those cells instead.  Also, future experiments 
should include using recombinant KITL in conjunction with an inhibitor to MAPK signaling to 
determine whether this pathway is truly regulating cyst breakdown as a result of activated KIT 
signaling.      
 Two BCL2 family proteins, BAX and MCL1, have been shown to be important to 
perinatal oocyte survival during cyst breakdown (Greenfeld et al. 2007, Jones & Pepling, in 
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review). The BCL2 family is a group of proteins primarily responsible for cell death and survival 
and can be divided into two main groups, those that are pro-apoptotic and those that are anti-
apoptotic.  When BAX, a pro-apoptotic protein, is knocked out, neonatal ovaries contain an 
increase in oocytes, suggesting a decrease in cell death when this death protein is eliminated 
(Greenfeld et al. 2007).  Likewise, when the anti-apoptotic protein MCL1 is inhibited in culture, 
ovaries contain fewer oocytes, indicating a need for MCL1 in perinatal oocyte survival. We 
hypothesized that MCL1 protein may be regulated by KIT signaling to alter germ cell survival, 
as we saw an increase in oocytes when KIT was blocked and a reduction in oocyte numbers 
when KIT signaling was activated.  Using Western blot on whole ovary protein extract, we found 
that KITL activated ovaries showed a complete absence of MCL1 protein when compared to 
control ovaries.  The lack of MCL1 in the KITL treated ovaries may explain the loss of germ 
cells that accompanied treatment with exogenous KITL.  These results contrast with those of Jin 
et al.(2005) who found that in cultured newborn rat ovaries, KITL increased cell survival 
through upregulation of two BCL2 anti-apoptotic proteins, BCL2 and BCLX.  The difference in 
action of KIT signaling between rat and mouse may be a species-specific difference in ovarian 
development.  One example of this is the contrasting action of GDF-9 in primordial follicle 
activation. In hamster, GDF-9 is responsible for the transition of primordial to primary follicle in 
vitro, but similar experiments in rat have shown GDF-9 to be important only in later follicle 
development, demonstrating a species-specific requirement of GDF-9 in primordial follicle 
activation (Nilsson & Skinner  2002, Wang & Roy 2006).  
 In summary, we have found a role for KIT in the formation of primordial follicles using 
an in vitro ovary culture system to block KIT signaling specifically at the time when cyst 
breakdown and primordial follicle formation begin.  While the in vitro system is a reliable 
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method for testing the effects of hormones and signaling molecules on ovarian development, 
they may not accurately reflect what is happening in vivo. Developing and evaluating a tissue 
specific knockout of the KIT receptor would shed light on the importance of this pathway during 
cyst breakdown in vivo. Additionally, studying the genes regulated downstream of KIT is 
essential to understanding its role in primordial follicle formation and further, in its effect on 
somatic cell division. Trombly et al.(2009), found that blocking Notch signaling in vitro resulted 
in a defect in primordial follicle formation in the mouse ovary.  Interestingly, the Notch receptor 
(NOTCH2) is expressed on the granulosa cells and its ligand, Jagged 1, is present in oocytes. 
This may be a pathway involved in an oocyte granulosa cell feedback system with the KITL/KIT 
system, where activation of KIT in the oocyte might upregulate JAGGED1 expression in the 
oocyte, resulting in communication with notch at the granulosa cells. Testing the expression of 
both NOTCH2 and JAGGED1 by quantitative RT-PCR or Western blot following organ culture 
with exogenous KITL would be a valuable follow up study.  Likewise, culture with recombinant 
KITL could be followed by a microarray analysis to determine the global genes being regulated 
by KIT signaling in the ovary during cyst breakdown. Finally, it would be interesting to 
determine if KIT signaling might act synergistically or redundantly with other pathways that 
have been identified as regulators of cyst breakdown and primordial follicle formation.  Studies 
examining connective tissue growth factor (CTGF) (Schindler et al. 2010) and nerve growth 
factor (NGF) (Dissen et al. 2001) have demonstrated a role for both of these signaling pathways 
in primordial follicle assembly and cyst breakdown, so experiments that explore the effects of 
inhibiting and activating multiple signaling pathways in conjunction with KIT could prove 
worthwhile. 
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CHAPTER 4:  
CONCLUSIONS AND FUTURE DIRECTIONS 
 Female fertility is established by the time of birth.  Fecundity is determined by the proper 
establishment of the primordial pool of follicles which requires precise control of cyst 
breakdown and regulation of oocyte numbers through apoptosis.  Improper control of these 
processes can lead to a number of fertility disorders.  It is believed that improper regulation of 
cyst breakdown and primordial follicle formation can lead to premature ovarian failure or 
primary amenorrhea, where an early depletion of oocytes leads to infertility (Yen & Jaffe 1991, 
Kezele & Skinner 2003). In addition, aberrant regulation of oocyte death as primordial follicles 
form may be the underlying cause of ovarian dysgerminoma, or germ cell tumors (Berek & 
Novak 2007). Little is known about what molecules regulate cyst breakdown, primordial follicle 
formation and oocyte death. The present research has illuminated the roles that BCL2, MCL1 
and KIT signaling play in these processes.  
 By evaluating transgenic mice, we have shown that the BCL2 protein is not primarily 
responsible for perinatal oocyte survival.  Interestingly, by PND 9, Flaws and colleagues (Flaws 
et al. 2001) found a marked increase in the number of primordial follicles present when BCL2 
was overexpressed.  This may mean that BCL2 is important during a recently discovered period 
of primordial follicle atresia, which begins after PND 6 (Tingen et al. 2009).  Alternatively, 
BCL2 may play a role in oocyte death during cyst breakdown, but its role may be redundant with 
other BCL2 antiapoptotic proteins. For example, Chao et al. (1995) found that in T cells BCL2 
and BCLX controlled a common pathway, such that T cell apoptosis in bcl2 knockout mice was 
rescued by expression of a bclx transgene in thymocytes.  In the same study it was found that the 
two molecules regulate the other’s expression, so as BCLX expression increased, BCL2 protein 
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was reduced.  If this were to be the case in the neonatal mouse ovary then expression of another 
BCL2 protein such as MCL1 may keep BCL2 downregulated enough so that knockout of BCL2 
may not cause an effect on oocyte survival.  Likewise, if BCL2 were to be eliminated, another 
BCL2 family protein’s expression may increase and substitute for its function in the oocyte.   
 BCL2 protein was shown to be expressed in oocytes but also in somatic cells within the 
ovary, and because of this, we cannot be sure that BCL2 exerts its effects in the oocyte rather 
than the granulosa cells. We did not quantify the number of granulosa cells within the ovary, so 
we cannot say whether BCL2 alters their survival. Somatic cells are important to the formation 
of primordial follicles and lower numbers may reduce cyst breakdown.  Therefore, granulosa cell 
numbers should be measured in neonatal BCL2 knockout and overexpressor ovaries by flow 
cytometry. Additionally, the expression pattern of BCL2 demonstrated stronger staining at PND 
3 than at earlier ages suggesting BCL2 may be important to later primordial follicle survival. A 
further study should examine germ cell numbers in a BCL2 knockout ovary after PND 7.  
 MCL1 is expressed in the mouse ovary from 17.5 dpc to PND 5, but its expression 
increased between 17.5 dpc and PND 3 indicating a possible role for this molecule during the 
peak time of oocyte loss and cyst breakdown.  To test that hypothesis, we cultured PND 1 
ovaries with an antibody to MCL1.  We found that MCL1 is very likely an important regulator of 
neonatal oocyte apoptosis.  Upon inhibition in culture, oocyte numbers in MCL1 inhibited 
ovaries (1:100 dilution) were reduced to 35% of controls.  This was a substantial loss of germ 
cells, however some oocytes survived despite MCL1 inhibition, even at the highest dilution.  
Several possible explanations may exist.  First, we began culture at PND 1, but evidence has 
shown that oocyte death and cyst breakdown begin earlier at 17.5 dpc (Pepling et al. 2010).  A 
future experiment may be to test oocyte survival upon MCL1 inhibition in culture beginning at 
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17.5 dpc.  This may result in loss of all the germ cells in the ovary. Another possible explanation 
is again the idea of BCL2 family redundancy.  It is entirely logical to hypothesize that in the 
absence of MCL1, the presence of another BCL2 protein may rescue some oocytes.  
Unpublished data from our lab showed that two antiapoptotic BCL2 family proteins, DIVA/BOO 
and A1 were expressed strongly in the oocyte at PND 1.  No research has been done on the role 
of either of these proteins in oocyte survival at any time point, so further experiments may 
investigate DIVA or A1 in conjunction with MCL1 in the ovary.   
 Using ovary organ culture, we were able to block MCL1 at different dosage levels and 
found that the loss of oocytes was dose dependent. This is an interesting finding, as it may lend 
support for the idea that a BCL2 family “rheostat” exists in cells where the balance of pro- and 
anti- apoptotic proteins determines cell survival or death (Chao & Korsmeyer 1998). In one 
study, when BAX was overexpressed in lymphocytes, cell death quickly ensued.  However, 
when BCL2 was overexpressed, it heterodimerized with BAX and cells survived (Oltvai et al. 
1993).  Our dose dependent results may be indicating a similar phenomenon.  It is possible that 
at the lower dilution (1:200), not enough free BAX exists in cells to increase apoptosis to a 
significant level, but as we double and quadruple MCL1 inhibition, more BAX is free to 
translocate to the mitochondria and homodimerize, releasing Cytochrome c and inducing 
apoptosis.             
 Our MCL1 experiments used in vitro methods to determine the role of MCL1 in oocyte 
survival because MCL1 knockout is embryonic lethal.  Contruction of a transgenic conditional 
oocyte-specific deletion of MCL1 would be very useful in determining the in vivo role of MCL1 
protein. Use of the Vasa-Cre line of mice  in conjunction with the floxed MCL1 mouse line 
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would ideally result in MCL1 deletion specifically in the oocyte beginning around 15.5 dpc 
when Vasa-Cre becomes active (Gallardo et al. 2007, Opferman et al. 2003). 
 KIT signaling has been important to many follicle transitions as well as fetal oocyte 
survival and development. Several labs have examined mice mutant for either the steel or W loci, 
and have found dramatic defects in PGC migration and proliferation that result in a complete loss 
of oocytes by birth (Reith et al. 1990, Huang et al. 1993). These mice are not optimal for 
observing the effects of KIT signaling on cyst breakdown as there are few oocytes, and cysts do 
not appear to form in these mutant ovaries. Other steel mutants show a decreased number of 
germ cells but normal primordial follicle formation (Bedell et al. 1995). However, these mice 
continue to secrete low amounts of KITL which may allow for normal cyst breakdown and 
follicle formation.  Due to the limitations of these genetic mutants, it was unclear whether KIT 
signaling played a role in perinatal cyst breakdown or oocyte survival.  Therefore, we set out to 
determine if the KITL/KIT system was important in early ovarian development. 
 KIT was expressed in only a few oocytes at 17.5 dpc but became expressed in a majority 
of germ cells beginning at 18.5 dpc.  By PND 1, expression in the oocyte cell membrane was 
strong except in a few oocytes within a cyst. Likewise, KITL expression increased in the oocyte 
from 17.5 dpc onward and remains expressed through PND 5.  These data imply that the 
components of KIT signaling are present during the time of cyst breakdown and oocyte death. 
 Interestingly, we found a few oocytes within a cyst did not express KIT.  We first thought 
that this may indicate cells that were destined for apoptosis.  However, co-labeling with an 
antibody to cleaved PARP demonstrated that cells absent for KIT were not necessarily set for 
death and that some cells staining positively for KIT were about to undergo apoptosis. It has 
been demonstrated that the KIT receptor ceases expression around 13.5-14.5 dpc, when germ 
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cells enter meiosis, and resumes expression at 17.5 dpc, when oocytes begin to arrest in the 
diplotene stage (Manova et al. 1990, Manova & Bachvarova 1991). It is possible that oocytes 
that are negative for the KIT label are cells that have not yet reached diplotene. In support of this 
idea, KIT appears to play a role in maintaining diplotene arrest later in follicle development, so 
KIT receptor may not be expressed until the oocytes have reached diplotene (Ismail et al. 1996, 
Ismail et al. 1997).  Premature expression may force germ cells to arrest in an earlier stage of 
prophase I, but this would need to be determined experimentally as there are no studies 
examining the relationship between KIT and meiosis in the fetal/neonatal ovary.  A more recent 
study examining expression of the KIT receptor found that protein expression correlated with 
zygotene/ pachytene stage oocytes at 16.5 dpc, although meiotic stage was not directly analyzed. 
Further investigation into the relationship between meiotic stage, KIT expression, meiotic 
progression and KIT signaling is warranted.       
   To test the hypothesis that KIT signaling might play a role in ovarian differentiation we 
employed an ovary organ culture system to specifically inhibit and activate KIT signaling during 
the period of cyst breakdown, primordial follicle formation and oocyte death.  We found that 
altering KIT signaling changed the ovarian histology, such that inhibition reduced primordial 
follicle formation and oocyte loss while activation promoted the formation of follicles and 
oocyte death.  These data support the findings of Wang and Roy (2004) that showed that 
exposing hamster ovaries to KITL in culture increased primordial follicle formation, however 
their work did not provide any information on the number of follicles present, so we do not know 
if adding KITL in culture accelerated death in hamster ovaries.  
 Our experiments showed an accelerated loss of oocytes on KIT activation and a decrease 
in oocyte death when KIT was blocked.  This seems to be in contrast to most of the other studies 
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that demonstrate that KIT is an important survival factor in the ovary. Only two of these, Jin et 
al. (2005) and Yoshida et al. (1997) have considered whole neonatal ovaries.  The first study 
considered neonatal rat ovaries and found that KIT signaling rescued oocyte loss when KITL 
was administered to ovaries in culture.  Likewise, oocyte death increased upon ACK2 exposure 
(Jin et al. 2005).  One important idea to consider that was mentioned in Chapter 3 is the notion of 
species specific differences.  It is entirely possible that rat and mouse ovaries have different 
responses to KIT signaling.  In addition, Jin and colleagues did not quantify or characterize cyst 
breakdown or primordial follicle formation.  Therefore, it may be that in rat there is an effect of 
KIT signaling on oocyte survival, but in mouse and hamster the effect is primarily on cyst 
breakdown.  Yoshida and colleagues (1997) used an injection of ACK2 every other day 
beginning on PND 1 to determine whether KIT signaling was important for follicle formation 
and oocyte survival in mouse ovaries.  This has been well addressed in Chapter 3, however one 
further point to mention is that in our data we also did not see an effect on oocyte numbers when 
culture with ACK2 began at PND 1.  This supports our argument that starting KIT inhibition at 
PND 1 may have been too late a time point to find an effect of KIT on oocyte numbers.  Finally, 
Lobascio et al. (2007) found that oocyte death was rescued by KITL when oocytes were cultured 
alone at 16.5 dpc, disaggregated from the rest of the ovarian cells.  While this does demonstrate 
that KIT signaling at the oocyte can increase its survival, the study disregards any contribution 
the granulosa cells may have in regulating KIT signaling and/or the existence of a granulosa cell-
oocyte feedback loop.  We showed that when KIT was blocked, granulosa cell mitosis decreased, 
implying that active KIT in the oocyte regulates a downstream molecule involved in granulosa 
cell communication.  Due to this interruption in communication and decrease in formation of 
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primordial follicles, germ cell death actually decreased, stressing the importance of the somatic 
cells in regulating oocyte survival and cyst breakdown.    
 Activin has been one of the few molecules shown to regulate KIT during cyst breakdown.  
Using fetal human ovary tissue samples, Coutts and colleagues (2008) were able to demonstrate 
that oocytes in cysts express KIT non-ubiquitously and those that are not expressing KIT express 
Activin. Interestingly, as Activin decreased in the oocyte, KIT was upregulated just prior to the 
time when cyst breakdown would begin.  However  when cultured with recombinant  Activin, 
ovarian expression of KITL was reduced to two-thirds of control levels, suggesting that Activin’s 
actions are on repressing KITL and that when KITL becomes expressed, KIT is then expressed.  
One study has demonstrated that KITL is able to upregulate KIT (Thomas et al. 2008).  All of 
this suggests a system in the ovary where Activin expression must be reduced in order for KIT  
evidence from Bristol-Gould et al. (2006) showed that ovaries from mice injected with 
recombinant Activin had an increased number of primordial follicles, which indicates Activin 
may accelerate cyst breakdown.  In contrast, Kimura et al. (2011) found that although there was 
an increase in primordial follicles when Follistatin, the negative regulator of Activin, was deleted 
from ovaries, cyst breakdown was delayed and occurred over a longer period of time, suggesting 
Activin may increase oocyte survival but delay follicle formation.  Our data may support a 
negative feedback loop where KIT signaling keeps Activin repressed, and when this happens too 
early, oocyte survival is markedly reduced. For example, when KIT signaling is activated at 17.5 
dpc, Activin could be downregulated too early and its survival signals lost so that as primordial 
follicles form, more oocytes die.  When KIT is inhibited at 17.5 dpc, Activin may be allowed to 
continue to signal for a longer period of time, increasing survival of oocytes, but inhibiting 
follicle formation.  Additionally, Activin has been shown to upregulate expression of MCL1 in 
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cells, so perhaps if Activin is downregulated too early, expression of MCL1 is not increased in 
time to rescue oocytes from apoptosis (Fukuchi et al. 2001).  In our study, we showed that when 
recombinant KITL was added to culture at 17.5 dpc, ovaries lacked MCL1 protein.  This may 
support a model for a KITL-Activin negative feedback loop that should be investigated further.   
 Increasingly, growth factor pathways are being identified that affect the perinatal survival 
of germ cells and the formation of primordial follicles, however none have been identified that 
have complete control of either cyst breakdown or oocyte survival.  This is likely due to 
regulation by a complex network of signaling molecules in these vital processes.  Even in our 
study, when ACK2 was used at a dilution of 1:100 to block KIT signaling, there were still over 
40% single oocytes in the KIT inhibited ovaries.  It is probable that other growth factor signaling 
is responsible for co-regulating cyst breakdown with KIT signaling, so that in the absence of one 
molecular signal another can still maintain primordial follicle formation, albeit in a reduced 
fashion.  Several possibilities exist for molecules that may work in concert with KIT to promote 
primordial follicle formation, and co-inhibition of KIT and other growth factors would be 
necessary to determine all of the factors that work together to carry out primordial follicle 
formation.  For instance, inhibition of KIT signaling in NGF knockout ovaries in culture may 
reveal a complete block on cyst breakdown, as NGF knockout ovaries have a large reduction in 
cyst breakdown (Dissen et al. 2001).  Other candidates for double inhibition with KIT might be 
GDF9 or BMP15, as adult knockout ovaries contain more MOFs (Yan et al. 2001).  
 Finally, as with the MCL1 studies, it is important to note that these experiments relied on 
in vitro culture and may not reflect what is happening in vivo.  If it is possible for ACK2 
antibody to cross the placenta, injecting pregnant dams at 17.5 dpc may be a way to evaluate in 
vivo effects of KIT inhibition.   Otherwise, a conditional knockout mouse would need to be made 
98 
 
in order to delete KIT protein during the time of primordial follicle formation.  Currently, no 
floxed KIT allele mice exist, so this type of mouse would first need to be constructed in order to 
generate conditional knockouts.   
 We have been the first to demonstrate the importance of MCL1 and KIT signaling in 
oocyte survival and primordial follicle formation in the mouse ovary.  This is an important step 
in the elucidation of mechanisms regulating cyst breakdown, oocyte numbers and primordial 
follicle formation which can lead to the development of early screens and interventions for 
infertility and germ cell cancers. Once mechanisms regulating these processes become known, it 
may be possible to screen for early genetic abnormalities or develop pharmacologic interventions 
for aberrant signaling in infertility or germ cell cancers. In addition, this research may be of 
significance in increasing fertility in endangered and agricultural species.  
 
 
 
 
 
 
 
 
 
 
 
 
99 
 
REFERENCES 
Adhikari D, Zheng W, Shen Y, Gorre N, Hamalainen T, Cooney AJ, Huhtaniemi I, Lan 
ZJ& Liu K 2010 Tsc/mTORC1 signaling in oocytes governs the quiescence and activation of 
primordial follicles. Human Molecular Genetics 19 397-410. 
Alvarez JV & Frank DA 2004 Genome-wide analysis of STAT target genes: elucidating the 
mechanism of STAT-mediated oncogenesis. Cancer Biology & Therapy 3 1045-1050. 
Ashman LK 1999 The biology of stem cell factor and its receptor C-kit. The International 
Journal of Biochemistry & Cell Biology 31 1037-1051. 
Bassik MC, Scorrano L, Oakes SA, Pozzan T & Korsmeyer SJ 2004 Phosphorylation of 
BCL-2 regulates ER Ca2+ homeostasis and apoptosis. The EMBO Journal 23 1207-1216. 
Bielanska-Osuchowska Z 2006 Oogenesis in pig ovaries during the prenatal period: 
ultrastructure and morphometry. Reproductive Biology 6 161-193. 
Borum K 1961 Oogenesis in the mouse. A study of the meiotic prophase. Experimental Cell 
Research 24 495-507. 
Boumela I, Assou S, Aouacheria A, Haouzi D, Dechaud H, De Vos J, Handyside A & 
Hamamah S 2011 Involvement of BCL2 family members in the regulation of human oocyte and 
early embryo survival and death: gene expression and beyond. Reproduction 141 549-561. 
Bristol-Gould SK, Kreeger PK, Selkirk CG, Kilen SM, Cook RW, Kipp JL, Shea LD, 
Mayo KE & Woodruff TK 2006 Postnatal regulation of germ cells by activin: the 
establishment of the initial follicle pool. Developmental Biology 298 132-148. 
Brown C, LaRocca J, Pietruska J, Ota M, Anderson L, Smith SD, Weston P, Rasoulpour T 
& Hixon ML 2010 Subfertility caused by altered follicular development and oocyte growth in 
female mice lacking PKB alpha/Akt1. Biology of Reproduction 82 246-256. 
Chao DT & Korsmeyer SJ 1998 BCL-2 family: regulators of cell death. Annual Review of 
Immunology 16 395-419. 
Chao DT, Linette GP, Boise LH, White LS, Thompson CB & Korsmeyer SJ 1995 Bcl-XL 
and Bcl-2 repress a common pathway of cell death. The Journal of Experimental Medicine 182 
821-828. 
Chen Y, Jefferson WN, Newbold RR, Padilla-Banks E & Pepling ME 2007 Estradiol, 
progesterone, and genistein inhibit oocyte nest breakdown and primordial follicle assembly in 
the neonatal mouse ovary in vitro and in vivo. Endocrinology 148 3580-3590. 
100 
 
Coucouvanis EC, Sherwood SW, Carswell-Crumpton C, Spack EG & Jones PP 1993 
Evidence That the Mechanism of Prenatal Germ Cell Death in the Mouse Is Apoptosis. 
Experimental Cell Research 209 238-247. 
Coutts SM, Childs AJ, Fulton N, Collins C, Bayne RA, McNeilly AS & Anderson RA 2008 
Activin signals via SMAD2/3 between germ and somatic cells in the human fetal ovary and 
regulates kit ligand expression. Developmental Biology 314 189-199. 
Danial NN 2007 BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clinical 
Cancer Research : an official journal of the American Association for Cancer Research 13 7254-
7263. 
Dissen GA, Romero C, Hirshfield AN & Ojeda SR 2001 Nerve growth factor is required for 
early follicular development in the mammalian ovary. Endocrinology 142 2078-2086. 
Dissen GA, Romero C, Paredes A & Ojeda SR 2002 Neurotrophic control of ovarian 
development. Microscopy Research and Technique 59 509-515. 
Elmore S 2007 Apoptosis: a review of programmed cell death. Toxicologic Pathology 35 495-
516. 
Elvin JA, Yan C, Wang P, Nishimori K & Matzuk MM 1999 Molecular characterization of 
the follicle defects in the growth differentiation factor 9-deficient ovary. Molecular 
Endocrinology 13 1018-1034. 
Faddy MJ, Jones EC & Edwards RG 1976 An analytical model for ovarian follicle dynamics. 
The Journal of experimental zoology 197 173-185. 
Farini D, La Sala G, Tedesco M & De Felici M 2007 Chemoattractant action and molecular 
signaling pathways of Kit ligand on mouse primordial germ cells. Developmental Biology 306 
572-583. 
Flaws JA, Hirshfield AN, Hewitt JA, Babus JK & Furth PA 2001 Effect of bcl-2 on the 
primordial follicle endowment in the mouse ovary. Biology of Reproduction 64 1153-1159. 
Fuchs Y & Steller H 2011 Programmed cell death in animal development and disease. Cell 147 
742-758. 
Fukuchi Y, Kizaki M, Yamato K, Kawamura C, Umezawa A, Hata J, Nishihara T & Ikeda 
Y 2001 Mcl-1, an early-induction molecule, modulates activin A-induced apoptosis and 
differentiation of CML cells. Oncogene 20 704-713. 
Gallardo T, Shirley L, John GB & Castrillon DH 2007 Generation of a germ cell-specific 
mouse transgenic Cre line, Vasa-Cre. Genesis 45 413-417. 
 
101 
 
Greenfeld CR, Pepling ME, Babus JK, Furth PA & Flaws JA 2007 BAX regulates follicular 
endowment in mice. Reproduction  133 865-876. 
Greenfeld CR, Roby KF, Pepling ME, Babus JK, Terranova PF & Flaws JA 2007 Tumor 
necrosis factor (TNF) receptor type 2 is an important mediator of TNF alpha function in the 
mouse ovary. Biology of Reproduction 76 224-231. 
Gumienny TL, Lambie E, Hartwieg E, Horvitz HR & Hengartner MO 1999 Genetic control 
of programmed cell death in the Caenorhabditis elegans hermaphrodite germline. Development 
126 1011-1022. 
Guo MW, Mori E, Xu JP & Mori T 1994 Identification of Fas antigen associated with 
apoptotic cell death in murine ovary. Biochemical and Biophysical Research Communications 
203 1438-1446. 
Hahn KL, Johnson J, Beres BJ, Howard S & Wilson-Rawls J 2005 Lunatic fringe null female 
mice are infertile due to defects in meiotic maturation. Development 132 817-828. 
Hartley PS, Bayne RA, Robinson LL, Fulton N & Anderson RA 2002 Developmental 
changes in expression of myeloid cell leukemia-1 in human germ cells during oogenesis and 
early folliculogenesis. The Journal of Clinical Endocrinology and Metabolism 87 3417-3427. 
Hirshfield AN 1991 Development of follicles in the mammalian ovary. International Review of 
Cytology 124 43-101. 
Hsueh AJ, McGee EA, Hayashi M & Hsu SY 2000 Hormonal regulation of early follicle 
development in the rat ovary. Molecular and Cellular Endocrinology 163 95-100. 
Hsu SY & Hsueh AJ 2000 Tissue-specific Bcl-2 protein partners in apoptosis: An ovarian 
paradigm. Physiological Reviews 80 593-614. 
Huang EJ, Manova K, Packer AI, Sanchez S, Bachvarova RF & Besmer P 1993 The murine 
steel panda mutation affects kit ligand expression and growth of early ovarian follicles. 
Developmental Biology 157 100-109. 
Huang EJ, Nocka KH, Buck J & Besmer P 1992 Differential expression and processing of two 
cell associated forms of the kit-ligand: KL-1 and KL-2. Molecular Biology of the Cell 3 349-362. 
Ismail RS, Dube M & Vanderhyden BC 1997 Hormonally regulated expression and alternative 
splicing of kit ligand may regulate kit-induced inhibition of meiosis in rat oocytes. 
Developmental Biology 184 333-342. 
Ismail RS, Okawara Y, Fryer JN & Vanderhyden BC 1996 Hormonal regulation of the 
ligand for c-kit in the rat ovary and its effects on spontaneous oocyte meiotic maturation. 
Molecular Reproduction and Development 43 458-469. 
102 
 
Jefferson W, Newbold R, Padilla-Banks E & Pepling M 2006 Neonatal genistein treatment 
alters ovarian differentiation in the mouse: inhibition of oocyte nest breakdown and increased 
oocyte survival. Biology of Reproduction 74 161-168. 
Jin X, Han CS, Yu FQ, Wei P, Hu ZY & Liu YX 2005 Anti-apoptotic action of stem cell 
factor on oocytes in primordial follicles and its signal transduction. Molecular Reproduction and 
Development 70 82-90. 
John GB, Gallardo TD, Shirley LJ & Castrillon DH 2008 Foxo3 is a PI3K-dependent 
molecular switch controlling the initiation of oocyte growth. Developmental Biology 321 197-
204. 
John GB, Shidler MJ, Besmer P & Castrillon DH 2009 Kit signaling via PI3K promotes 
ovarian follicle maturation but is dispensable for primordial follicle activation. Developmental 
Biology 331 292-299. 
Johnson J, Canning J, Kaneko T, Pru JK & Tilly JL 2004 Germline stem cells and follicular 
renewal in the postnatal mammalian ovary. Nature 428 145-150. 
Johnson J, Espinoza T, McGaughey RW, Rawls A & Wilson-Rawls J 2001 Notch pathway 
genes are expressed in mammalian ovarian follicles. Mechanisms of Development 109 355-361. 
Jones RL & Pepling ME  Role of the anti-apoptotic proteins BCL2 and MCL1 in the neonatal 
mouse ovary.  Biology of Reproduction in review. 
Karavan JR & Pepling ME 2012 Effects of estrogenic compounds on neonatal oocyte 
development. Reproductive Toxicology 34 51-56. 
Kerr B, Garcia-Rudaz C, Dorfman M, Paredes A & Ojeda SR 2009 NTRK1 and NTRK2 
receptors facilitate follicle assembly and early follicular development in the mouse ovary. 
Reproduction  138 131-140. 
Keshet E, Lyman SD, Williams DE, Anderson DM, Jenkins NA, Copeland NG & Parada 
LF 1991 Embryonic RNA expression patterns of the c-kit receptor and its cognate ligand suggest 
multiple functional roles in mouse development. The EMBO Journal 10 2425-2435. 
Kim H, Nakajima T, Hayashi S, Chambon P, Watanabe H, Iguchi T & Sato T 2009 Effects 
of diethylstilbestrol on programmed oocyte death and induction of polyovular follicles in 
neonatal mouse ovaries. Biology of Reproduction 81 1002-1009. 
Kim MR & Tilly JL 2004 Current concepts in Bcl-2 family member regulation of female germ 
cell development and survival. Biochimica et Biophysica Acta 1644 205-210. 
Kimura F, Bonomi LM & Schneyer AL 2011 Follistatin regulates germ cell nest breakdown 
and primordial follicle formation. Endocrinology 152 697-706. 
103 
 
Kissel H, Timokhina I, Hardy MP, Rothschild G, Tajima Y, Soares V, Angeles M, Whitlow 
SR, Manova K & Besmer P 2000 Point mutation in kit receptor tyrosine kinase reveals 
essential roles for kit signaling in spermatogenesis and oogenesis without affecting other kit 
responses. The EMBO Journal 19 1312-1326. 
Kozopas KM, Yang T, Buchan HL, Zhou P & Craig RW 1993 MCL1, a gene expressed in 
programmed myeloid cell differentiation, has sequence similarity to BCL2. Proceedings of the 
National Academy of Sciences of the United States of America 90 3516-3520. 
Lavrik I, Golks A & Krammer PH 2005 Death receptor signaling. Journal of Cell Science 118 
265-267. 
Little CC & Cloudman AM 1937 The Occurrence of a Dominant Spotting Mutation in the 
House Mouse. Proceedings of the National Academy of Sciences of the United States of America 
23 535-537. 
Liu H, Luo LL, Qian YS, Fu YC, Sui XX, Geng YJ, Huang DN, Gao ST & Zhang RL 2009 
FOXO3a is involved in the apoptosis of naked oocytes and oocytes of primordial follicles from 
neonatal rat ovaries. Biochemical and Biophysical Research Communications 381 722-727. 
Lobascio AM, Klinger FG, Scaldaferri ML, Farini D & De Felici M 2007 Analysis of 
programmed cell death in mouse fetal oocytes. Reproduction  134 241-252. 
Lyrakou S, Hulten MA & Hartshorne GM 2002 Growth factors promote meiosis in mouse 
fetal ovaries in vitro. Molecular Human Reproduction 8 906-911. 
Manova K & Bachvarova RF 1991 Expression of c-kit encoded at the W locus of mice in 
developing embryonic germ cells and presumptive melanoblasts. Developmental Biology 146 
312-324. 
Manova K, Nocka K, Besmer P & Bachvarova RF 1990 Gonadal expression of c-kit encoded 
at the W locus of the mouse. Development 110 1057-1069. 
Matsui Y, Toksoz D, Nishikawa S, Nishikawa S, Williams D, Zsebo K & Hogan BL 1991 
Effect of Steel factor and leukaemia inhibitory factor on murine primordial germ cells in culture. 
Nature 353 750-752. 
Matsui Y, Zsebo KM & Hogan BL 1990 Embryonic expression of a haematopoietic growth 
factor encoded by the Sl locus and the ligand for c-kit. Nature 347 667-669. 
Mazaud S, Guyot R, Guigon CJ, Coudouel N, Le Magueresse-Battistoni B & Magre S 2005 
Basal membrane remodeling during follicle histogenesis in the rat ovary: contribution of 
proteinases of the MMP and PA families. Developmental Biology 277 403-416. 
McCoshen JA & McCallion DJ 1975 A study of the primordial germ cells during their 
migratory phase in Steel mutant mice. Experientia 31 589-590. 
104 
 
McGrath SA, Esquela AF & Lee SJ 1995 Oocyte-specific expression of growth/differentiation 
factor-9. Molecular Endocrinology 9 131-136. 
Memon MA, Anway MD, Covert TR, Uzumcu M & Skinner MK 2008 Transforming growth 
factor beta (TGFbeta1, TGFbeta2 and TGFbeta3) null-mutant phenotypes in embryonic gonadal 
development. Molecular and Cellular Endocrinology 294 70-80. 
Menke DB, Koubova J & Page DC 2003 Sexual differentiation of germ cells in XX mouse 
gonads occurs in an anterior-to-posterior wave. Developmental Biology 262 303-312. 
Miyazawa K, Williams DA, Gotoh A, Nishimaki J, Broxmeyer HE & Toyama K 1995 
Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life 
span of c-kit gene-encoded protein than its soluble form. Blood 85 641-649. 
Moniruzzaman M, Sakamaki K, Akazawa Y & Miyano T 2007 Oocyte growth and follicular 
development in KIT-deficient Fas-knockout mice. Reproduction  133 117-125. 
Morrison LJ & Marcinkiewicz JL 2002 Tumor necrosis factor alpha enhances oocyte/follicle 
apoptosis in the neonatal rat ovary. Biology of Reproduction 66 450-457. 
Murphy K, Carvajal L, Medico L & Pepling M 2005 Expression of Stat3 in germ cells of 
developing and adult mouse ovaries and testes. Gene Expression Patterns : GEP 5 475-482. 
Myers M, Tripurani SK, Middlebrook B, Economides AN, Canalis E & Pangas SA 2011 
Loss of gremlin delays primordial follicle assembly but does not affect female fertility in mice. 
Biology of Reproduction 85 1175-1182. 
Nilsson EE, Kezele P & Skinner MK 2002 Leukemia inhibitory factor (LIF) promotes the 
primordial to primary follicle transition in rat ovaries. Molecular and Cellular Endocrinology 
188 65-73. 
Nilsson EE & Skinner MK 2002 Growth and differentiation factor-9 stimulates progression of 
early primary but not primordial rat ovarian follicle development. Biology of Reproduction 67 
1018-1024. 
Nilsson EE & Skinner MK 2004 Kit ligand and basic fibroblast growth factor interactions in 
the induction of ovarian primordial to primary follicle transition. Molecular and Cellular 
Endocrinology 214 19-25. 
Oltvai ZN, Milliman CL & Korsmeyer SJ 1993 Bcl-2 heterodimerizes in vivo with a 
conserved homolog, Bax, that accelerates programmed cell death. Cell 74 609-619. 
Opferman JT 2008 Apoptosis in the development of the immune system. Cell Death and 
Differentiation 15 234-242. 
105 
 
Otsuka F & Shimasaki S 2002 A negative feedback system between oocyte bone 
morphogenetic protein 15 and granulosa cell kit ligand: its role in regulating granulosa cell 
mitosis. Proceedings of the National Academy of Sciences of the United States of America 99 
8060-8065. 
Parrott JA & Skinner MK 1999 Kit-ligand/stem cell factor induces primordial follicle 
development and initiates folliculogenesis. Endocrinology 140 4262-4271. 
Pepling ME, de Cuevas M & Spradling AC 1999 Germline cysts: a conserved phase of germ 
cell development? Trends in cell Biology 9 257-262. 
Pepling ME & Spradling AC 1998 Female mouse germ cells form synchronously dividing 
cysts. Development 125 3323-3328. 
Pepling ME & Spradling AC 2001 Mouse ovarian germ cell cysts undergo programmed 
breakdown to form primordial follicles. Developmental Biology 234 339-351. 
Pepling ME, Sundman EA, Patterson NL, Gephardt GW, Medico L,Jr & Wilson KI 2010 
Differences in oocyte development and estradiol sensitivity among mouse strains. Reproduction   
139 349-357. 
Perez GI, Robles R, Knudson CM, Flaws JA, Korsmeyer SJ & Tilly JL 1999 Prolongation 
of ovarian lifespan into advanced chronological age by Bax-deficiency. Nature Genetics 21 200-
203. 
Peters H 1969 The development of the mouse ovary from birth to maturity. Acta 
Endocrinologica 62 98-116. 
Peters H 1970 Migration of gonocytes into the mammalian gonad and their differentiation. 
Philosophical transactions of the Royal Society of London.Series B, Biological sciences 259 91-
101. 
Pritchett TL, Tanner EA & McCall K 2009 Cracking open cell death in the Drosophila ovary. 
Apoptosis : An International Journal on Programmed Cell Death 14 969-979. 
Rajareddy S, Reddy P, Du C, Liu L, Jagarlamudi K, Tang W, Shen Y, Berthet C, Peng SL, 
Kaldis P & Liu K 2007 p27kip1 (cyclin-dependent kinase inhibitor 1B) controls ovarian 
development by suppressing follicle endowment and activation and promoting follicle atresia in 
mice. Molecular Endocrinology 21 2189-2202. 
Ratts VS, Flaws JA, Kolp R, Sorenson CM & Tilly JL 1995 Ablation of bcl-2 gene 
expression decreases the numbers of oocytes and primordial follicles established in the post-natal 
female mouse gonad. Endocrinology 136 3665-3668. 
106 
 
Reddy P, Liu L, Adhikari D, Jagarlamudi K, Rajareddy S, Shen Y, Du C, Tang W, 
Hamalainen T, Peng SL, Lan ZJ, Cooney AJ, Huhtaniemi I & Liu K 2008 Oocyte-specific 
deletion of Pten causes premature activation of the primordial follicle pool. Science 319 611-613. 
Reynaud K, Cortvrindt R, Smitz J, Bernex F, Panthier JJ & Driancourt MA 2001 
Alterations in ovarian function of mice with reduced amounts of KIT receptor. Reproduction  
121 229-237. 
Riedlinger G, Okagaki R, Wagner KU, Rucker EB,3rd, Oka T, Miyoshi K, Flaws JA & 
Hennighausen L 2002 Bcl-x is not required for maintenance of follicles and corpus luteum in 
the postnatal mouse ovary. Biology of Reproduction 66 438-444. 
Rinkenberger JL, Horning S, Klocke B, Roth K & Korsmeyer SJ 2000 Mcl-1 deficiency 
results in peri-implantation embryonic lethality. Genes & Development 14 23-27. 
Roskoski R,Jr 2005 Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor 
receptor. Biochemical and Biophysical Research Communications 338 1307-1315. 
Rucker EB,3rd, Dierisseau P, Wagner KU, Garrett L, Wynshaw-Boris A, Flaws JA & 
Hennighausen L 2000 Bcl-x and Bax regulate mouse primordial germ cell survival and 
apoptosis during embryogenesis. Molecular Endocrinology 14 1038-1052. 
Russe I 1983 Oogenesis in cattle and sheep. Bibliotheca Anatomica 24 77-92. 
Saffman EE & Lasko P 1999 Germline development in vertebrates and invertebrates. Cellular 
and Molecular Life Sciences : CMLS 55 1141-1163. 
Sakata S, Sakamaki K, Watanabe K, Nakamura N, Toyokuni S, Nishimune Y, Mori C & 
Yonehara S 2003 Involvement of death receptor Fas in germ cell degeneration in gonads of Kit-
deficient Wv/Wv mutant mice. Cell Death and Differentiation 10 676-686. 
Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer 
PH & Peter ME 1998 Two CD95 (APO-1/Fas) signaling pathways. The EMBO Journal 17 
1675-1687. 
Schindler R, Nilsson E & Skinner MK 2010 Induction of ovarian primordial follicle assembly 
by connective tissue growth factor CTGF. PloS One 5 e12979. 
Schlessinger J 2000 Cell signaling by receptor tyrosine kinases. Cell 103 211-225. 
Schmitz I, Kirchhoff S & Krammer PH 2000 Regulation of death receptor-mediated apoptosis 
pathways. The International Journal of Biochemistry & Cell Biology 32 1123-1136. 
Smith P, O WS, Hudson NL, Shaw L, Heath DA, Condell L, Phillips DJ & McNatty KP 
1993 Effects of the Booroola gene (FecB) on body weight, ovarian development and hormone 
concentrations during fetal life. Journal of Reproduction and Fertility 98 41-54. 
107 
 
Spears N, Molinek MD, Robinson LL, Fulton N, Cameron H, Shimoda K, Telfer EE, 
Anderson RA & Price DJ 2003 The role of neurotrophin receptors in female germ-cell survival 
in mouse and human. Development 130 5481-5491. 
Sun J, Pedersen M & Ronnstrand L 2008 Gab2 is involved in differential phosphoinositide 3-
kinase signaling by two splice forms of c-Kit. The Journal of Biological Chemistry 283 27444-
27451. 
Thomas FH, Ismail RS, Jiang JY & Vanderhyden BC 2008 Kit ligand 2 promotes murine 
oocyte growth in vitro. Biology of Reproduction 78 167-175. 
Tingen CM, Bristol-Gould SK, Kiesewetter SE, Wellington JT, Shea L & Woodruff TK 
2009 Prepubertal primordial follicle loss in mice is not due to classical apoptotic pathways. 
Biology of Reproduction 81 16-25. 
Trombly DJ, Woodruff TK & Mayo KE 2009 Suppression of Notch signaling in the neonatal 
mouse ovary decreases primordial follicle formation. Endocrinology 150 1014-1024. 
Wang C & Roy SK 2006 Expression of growth differentiation factor 9 in the oocytes is essential 
for the development of primordial follicles in the hamster ovary. Endocrinology 147 1725-1734. 
Wang J & Roy SK 2004 Growth differentiation factor-9 and stem cell factor promote 
primordial follicle formation in the hamster: modulation by follicle-stimulating hormone. 
Biology of Reproduction 70 577-585. 
Wiersma A, Hirsch B, Tsafriri A, Hanssen RG, Van de Kant M, Kloosterboer HJ, Conti M 
& Hsueh AJ 1998 Phosphodiesterase 3 inhibitors suppress oocyte maturation and consequent 
pregnancy without affecting ovulation and cyclicity in rodents. The Journal of Clinical 
Investigation 102 532-537. 
Yan C, Wang P, DeMayo J, DeMayo FJ, Elvin JA, Carino C, Prasad SV, Skinner SS, 
Dunbar BS, Dube JL, Celeste AJ & Matzuk MM 2001 Synergistic roles of bone 
morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Molecular 
Endocrinology 15 854-866. 
Yoshida H, Takakura N, Kataoka H, Kunisada T, Okamura H & Nishikawa SI 1997 
Stepwise requirement of c-kit tyrosine kinase in mouse ovarian follicle development. 
Developmental Biology 184 122-137. 
Yuan J &Yankner BA 2000 Apoptosis in the nervous system. Nature 407 802-809. 
Zamboni L 1974 Fine morphology of the follicle wall and follicle cell-oocyte association. 
Biology of Reproduction 10 125-149. 
 
108 
 
Curriculum Vitae 
 
Robin L. Jones 
 
7642 Harbor Circle          
 (315)877-6515  
Liverpool, NY 13090          
 rljone02@syr.edu 
 
EDUCATION 
 
Ph.D.   2012  Cell and Molecular Biology, Syracuse University. Expected graduation Fall 2012. 
  Dissertation: Roles of kit signaling, Bcl2 and Mcl1 in perinatal oocyte cyst breakdown and 
survival.  
 
M.S.     2002 Science Education, Syracuse University  
 
B.S.      1998 Respiratory Care, SUNY Upstate Medical University 
 
 
RESEARCH EXPERIENCE 
 
Mechanisms of  Perinatal Germ Cell Death and Oocyte Cyst Breakdown 
 2007-2012 LAB: Dr. Melissa Pepling, Syracuse University 
  
 Project: Identify members of the Bcl-2 family involved in oocyte survival as primordial follicles 
form.   
 Analyzed effects of overexpression and deletion of Bcl2 protein on follicle 
development in female mice.   
 Characterized expression of Mcl1 protein in the oocyte and its role in survival in 
organ culture 
 
 Project: Characterize the role of  kit signaling in oocyte cyst breakdown, survival, and follicle 
formation. 
 Tested the expression of kit receptor and ligand using immunohistochemistry 
 Identified the role of kit signaling in cyst breakdown and oocyte survival using organ 
culture 
 Clarified the effect of kit signaling on cell death and division using 
immunohistochemistry 
 Elucidated the downstream pathways used to effect cyst breakdown and survival 
using Western Blotting 
 
LABORATORY SKILLS 
 
 Immunohistochemistry/Whole mount ovary antibody staining 
 Western Blotting 
 Organ culture  
 Confocal microscopy 
 PCR 
109 
 
 DNA isolation and purification 
 Gel electrophoresis 
 Cell death analysis using immunohistochemistry 
 Mouse colony management 
 Mouse genotyping including ear tagging and tail snips 
 Mouse dissection including fetal pup dissection 
 Proficient with SPSS, Microsoft Office and Adobe Photoshop software 
 
 
 
PUBLICATIONS 
  
Accepted with revisions 
 Jones, RL and Pepling, ME. Role of the anti-apoptotic proteins Bcl2 and Mcl1 in the neonatal 
mouse ovary.  Biology of Reproduction. 
 
Manuscripts in progress 
 Jones, RL and Pepling, ME. Kit signaling regulates oocyte cyst breakdown in the neonatal mouse 
ovary. 
 
INVITED PRESENTATIONS 
 
2010  Jones, RL and Pepling, ME.  Evidence that Bcl2 is dispensable for neonatal ovarian 
oocyte survival.  
  Society for the Study of Reproduction Annual Meeting, Milwaukee, WI. 
 
2011  Jones, RL and Pepling, ME.  Mechanisms of ovarian germ cell apoptosis and follicle 
formation: The    role of  Bcl2 and kit signaling. Central New York Developmental 
Biology Interest Group, Syracuse,    NY. 
 
2011  Jones, RL and Pepling, ME. Role of Bcl2 in Oocyte Survival.  1
st
 Annual Life  Sciences 
Symposium,    Syracuse,  NY.    
 
2011   Jones, RL and Pepling, ME. Kit signaling promotes oocyte cyst breakdown and 
primordial follicle    formation in the mouse ovary.  Society for the Study of 
Reproduction Annual Meeting, Portland, OR. 
 
2012   Jones, RL and Pepling, ME.  Mouse ovarian development and the role of kit signaling. 
Syracuse    University Graduate Recruitment Day, Syracuse, NY. 
 
2012  Jones, RL and Pepling, ME.  Role of the anti-apoptotic  proteins Bcl2 and Mcl1 in 
perinatal oocyte    survival. 2
nd
 Annual Life Sciences Symposium, Syracuse, NY.   
 
TEACHING EXPERIENCE 
 
Spring 2009  Introduction to Biology      Syracuse University 
    
Fall 2009, 2010 Genetics Laboratory       Syracuse University 
   
110 
 
Spring 2010, 2012 Cell and Developmental Biology Laboratory    Syracuse 
University 
 
Spring 2011  Molecular Biology Laboratory      Syracuse University 
 
Spring 2007  Current Research in Science Education    Syracuse University 
 
Fall 2006  Science Teaching Methods      Syracuse 
University 
 
2004-2006  Biology Teacher      Liverpool High 
School 
 
2003-2004  Science Teacher      Bloomfield 
Middle School 
 
Fall 2001, 2002 Elementary Science Education Methods   Syracuse University  
 
UNIVERSITY SERVICE 
 
 Member, Institutional Animal Care and Use Committee, Syracuse University 
 Graduate Student Member, Graduate Education and Recruitment Committee, Syracuse 
University 
 Member, Tenure Committee, Biology Department, Syracuse University 
 Listserv Manager, Graduate Student Organization, Biology Department, Syracuse 
University 
 
AWARDS AND HONORS 
 
 Member of Phi Kappa Phi 
 Academic fellowship Syracuse University 
 Society for Study of Reproduction trainee travel grant award 
 Syracuse University Graduate Student travel award 
 Syracuse University Biology travel award 
 Clinical excellence award  SUNY Health Science Center 
 Magna Cum Laude SUNY Health Science Center 
 
PROFESSIONAL AFFILIATIONS 
 
2010- PRESENT Society for the Study of Reproduction 
2011- PRESENT American  Association for the Advancement of Science 
 
 
 
REFERENCES 
 
Melissa Pepling, Ph.D.     Scott Erdman, Ph.D.    
  
Associate Professor      Associate Professor 
Department of Biology      Department of Biology 
111 
 
Syracuse University      Syracuse University 
Syracuse, NY 13244      Syracuse, NY 13244  
Phone: (315) 443-4541     Phone: (314) 443-3748 
Fax: (315) 443-2012       Fax: (315) 443-2012   
Email: mepeplin@syr.edu     Email: seerdman@syr.edu 
 
 
Eleanor Maine, Ph.D.      John Belote, Ph.D 
Professor       Professor 
Department of Biology      Department of Biology 
Syracuse University      Syracuse University 
Syracuse, NY 13244      Syracuse, NY 13244 
Phone: (315) 443-9169     Phone: (315) 443-3695 
Fax: (315) 443-2012       Fax: (315) 443-2012  
Email: emmaine@syr.edu     Email: jbelote@syr.edu 
 
 
 
 
  
